{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:07:36Z","timestamp":1790723256294,"version":"4.1.0"},"reference-count":392,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T00:00:00Z","timestamp":1524960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12035-018-1092-y","type":"journal-article","created":{"date-parts":[[2018,4,28]],"date-time":"2018-04-28T18:29:06Z","timestamp":1524940146000},"page":"406-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Could Alzheimer\u2019s Disease Originate in the Periphery and If So How So?"],"prefix":"10.1007","volume":"56","author":[{"given":"Gerwyn","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basant K.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,29]]},"reference":[{"issue":"2","key":"1092_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","volume":"14","author":"PH Reddy","year":"2008","unstructured":"Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer\u2019s disease. Trends Mol Med 14(2):45\u201353. \n                    https:\/\/doi.org\/10.1016\/j.molmed.2007.12.002","journal-title":"Trends Mol Med"},{"issue":"7","key":"1092_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-\u03b2 in Alzheimer\u2019s disease. Nat Rev Neurosci 8(7):499\u2013509. \n                    https:\/\/doi.org\/10.1038\/nrn2168","journal-title":"Nat Rev Neurosci"},{"issue":"7000","key":"1092_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Pathways towards and away from Alzheimer\u2019s disease. Nature 430(7000):631\u2013639. \n                    https:\/\/doi.org\/10.1038\/nature02621","journal-title":"Nature"},{"issue":"1","key":"1092_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34(1):185\u2013204. \n                    https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113613","journal-title":"Annu Rev Neurosci"},{"key":"1092_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"YW Zhang","year":"2011","unstructured":"Zhang YW, Thompson R, Zhang H, Xu H (2011) APP processing in Alzheimer\u2019s disease. Mol Brain 4:3. \n                    https:\/\/doi.org\/10.1186\/1756-6606-4-3","journal-title":"Mol Brain"},{"issue":"5","key":"1092_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt211","volume":"5","author":"X Zhang","year":"2013","unstructured":"Zhang X, Song W (2013) The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation. Alzheimers Res Ther 5(5):46. \n                    https:\/\/doi.org\/10.1186\/alzrt211","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1092_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/156720512799361673","volume":"9","author":"U Konietzko","year":"2012","unstructured":"Konietzko U (2012) AICD nuclear signaling and its possible contribution to Alzheimers disease. Curr Alzheimer Res 9(2):200\u2013216. \n                    https:\/\/doi.org\/10.2174\/156720512799361673","journal-title":"Curr Alzheimer Res"},{"key":"1092_CR8","doi-asserted-by":"publisher","unstructured":"De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer\u2019s disease. Protein aggregation and fibrillogenesis in cerebral and systemic amyloid disease Springer Netherlands doi:\n                    https:\/\/doi.org\/10.1007\/978-94-007-5416-4_14","DOI":"10.1007\/978-94-007-5416-4_14"},{"key":"1092_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40478-014-0135-5","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris GP, Clark IA, Vissel B (2014) Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease. Acta Neuropathol Commun 2:135. \n                    https:\/\/doi.org\/10.1186\/s40478-014-0135-5","journal-title":"Acta Neuropathol Commun"},{"key":"1092_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","volume":"2","author":"G Chetelat","year":"2013","unstructured":"Chetelat G, La Joie R, Villain N, Perrotin A, de La Sayette V, Eustache F, Vandenberghe R (2013) Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer\u2019s disease. Neuroimage Clin 2:356\u2013365. \n                    https:\/\/doi.org\/10.1016\/j.nicl.2013.02.006","journal-title":"Neuroimage Clin"},{"issue":"5","key":"1092_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","volume":"62","author":"MA Greenough","year":"2013","unstructured":"Greenough MA, Camakaris J, Bush AI (2013) Metal dyshomeostasis and oxidative stress in Alzheimer\u2019s disease. Neurochem Int 62(5):540\u2013555. \n                    https:\/\/doi.org\/10.1016\/j.neuint.2012.08.014","journal-title":"Neurochem Int"},{"key":"1092_CR12","doi-asserted-by":"publisher","unstructured":"Llorens-Mar\u00c3\u00adtin Ma, Jurado Jn, Hern\u00c3\u00a1ndez Fl, \u00c3vila Js (2014) GSK-3\u00ce2, a pivotal kinase in Alzheimer disease. Front Mol Neurosci 7. doi:\n                    https:\/\/doi.org\/10.3389\/fnmol.2014.00046","DOI":"10.3389\/fnmol.2014.00046"},{"key":"1092_CR13","doi-asserted-by":"publisher","unstructured":"Skaper SD (2012) Alzheimer\u2019s disease and amyloid: culprit or coincidence? Int Rev Neurobiol Elsevier. \n                    https:\/\/doi.org\/10.1016\/b978-0-12-386986-9.00011-9","DOI":"10.1016\/b978-0-12-386986-9.00011-9"},{"issue":"9","key":"1092_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/s1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10(9):785\u2013796. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(11)70156-9","journal-title":"Lancet Neurol"},{"issue":"8","key":"1092_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2174\/1567205013666160219113112","volume":"13","author":"G Morris","year":"2016","unstructured":"Morris G, Berk M (2016) The putative use of lithium in Alzheimer\u2019s disease. Curr Alzheimer Res 13(8):853\u2013861","journal-title":"Curr Alzheimer Res"},{"key":"1092_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2013\/316523","volume":"2013","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhao B (2013) Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxidative Med Cell Longev 2013:10. \n                    https:\/\/doi.org\/10.1155\/2013\/316523","journal-title":"Oxidative Med Cell Longev"},{"issue":"4","key":"1092_CR17","first-page":"401","volume":"25","author":"M Padurariu","year":"2013","unstructured":"Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R (2013) The oxidative stress hypothesis in Alzheimer\u2019s disease. Psychiatr Danub 25(4):401\u2013409","journal-title":"Psychiatr Danub"},{"issue":"Suppl 2","key":"1092_CR18","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.3233\/jad-2010-100339","volume":"20","author":"RH Swerdlow","year":"2010","unstructured":"Swerdlow RH, Burns JM, Khan SM (2010) The Alzheimer\u2019s disease mitochondrial cascade hypothesis. J Alzheimer\u2019s Dis : JAD 20(Suppl 2):S265\u2013S279. \n                    https:\/\/doi.org\/10.3233\/jad-2010-100339","journal-title":"J Alzheimer\u2019s Dis : JAD"},{"issue":"1","key":"1092_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","volume":"1802","author":"PI Moreira","year":"2010","unstructured":"Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G (2010) Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology. Biochim Biophys Acta (BBA) - Mol Basis Dis 1802(1):2\u201310. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2009.10.006","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"3","key":"1092_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/brain\/aww349","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan Z, Brooks DJ, Okello A, Edison P (2017) An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain 140(3):792\u2013803. \n                    https:\/\/doi.org\/10.1093\/brain\/aww349","journal-title":"Brain"},{"issue":"Pt 12","key":"1092_CR21","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/brain\/awv288","volume":"138","author":"Z Fan","year":"2015","unstructured":"Fan Z, Okello AA, Brooks DJ, Edison P (2015) Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease. Brain 138(Pt 12):3685\u20133698. \n                    https:\/\/doi.org\/10.1093\/brain\/awv288","journal-title":"Brain"},{"issue":"2","key":"1092_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.trci.2016.05.001","volume":"2","author":"LJ Eldik Van","year":"2016","unstructured":"Van Eldik LJ, Carrillo MC, Cole PE, Feuerbach D, Greenberg BD, Hendrix JA, Kennedy M, Kozauer N et al (2016) The roles of inflammation and immune mechanisms in Alzheimer\u2019s disease. Alzheimer\u2019s Dement: Transl Res Clin Interv 2(2):99\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.trci.2016.05.001","journal-title":"Alzheimer\u2019s Dement: Transl Res Clin Interv"},{"issue":"3","key":"1092_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10571-016-0386-8","volume":"37","author":"Q Li","year":"2017","unstructured":"Li Q, Liu Y, Sun M (2017) Autophagy and Alzheimer\u2019s disease. Cell Mol Neurobiol 37(3):377\u2013388. \n                    https:\/\/doi.org\/10.1007\/s10571-016-0386-8","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"1092_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1515\/revneuro-2014-0076","volume":"26","author":"A Zare-shahabadi","year":"2015","unstructured":"Zare-shahabadi A, Masliah E, Johnson GVW, Rezaei N (2015) Autophagy in Alzheimer\u2019s disease. Rev Neurosci 26(4):385\u2013395. \n                    https:\/\/doi.org\/10.1515\/revneuro-2014-0076","journal-title":"Rev Neurosci"},{"issue":"3","key":"1092_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1179\/1743132813y.0000000288","volume":"36","author":"L Hong","year":"2014","unstructured":"Hong L, Huang HC, Jiang ZF (2014) Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer\u2019s disease. Neurol Res 36(3):276\u2013282. \n                    https:\/\/doi.org\/10.1179\/1743132813y.0000000288","journal-title":"Neurol Res"},{"key":"1092_CR26","doi-asserted-by":"publisher","unstructured":"Gong B, Radulovic M, Figueiredo-Pereira ME, Cardozo C (2016) The ubiquitin-proteasome system: potential therapeutic targets for Alzheimer\u2019s disease and spinal cord injury. Front Mol Neurosci 9(4). \n                    https:\/\/doi.org\/10.3389\/fnmol.2016.00004","DOI":"10.3389\/fnmol.2016.00004"},{"issue":"5","key":"1092_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/jnc.13037","volume":"133","author":"A Tramutola","year":"2015","unstructured":"Tramutola A, Triplett JC, Di Domenico F, Niedowicz DM, Murphy MP, Coccia R, Perluigi M, Butterfield DA (2015) Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. J Neurochem 133(5):739\u2013749. \n                    https:\/\/doi.org\/10.1111\/jnc.13037","journal-title":"J Neurochem"},{"key":"1092_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/427318","volume":"2014","author":"T Persson","year":"2014","unstructured":"Persson T, Popescu BO, Cedazo-Minguez A (2014) Oxidative stress in Alzheimer\u2019s disease: why did antioxidant therapy fail? Oxidative Med Cell Longev 2014:1\u201311. \n                    https:\/\/doi.org\/10.1155\/2014\/427318","journal-title":"Oxidative Med Cell Longev"},{"key":"1092_CR29","doi-asserted-by":"publisher","unstructured":"Sontag J-M, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease. Front Mol Neurosci 7(16). \n                    https:\/\/doi.org\/10.3389\/fnmol.2014.00016","DOI":"10.3389\/fnmol.2014.00016"},{"issue":"11","key":"1092_CR30","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s11064-007-9394-x","volume":"32","author":"TD Foley","year":"2007","unstructured":"Foley TD, Petro LA, Stredny CM, Coppa TM (2007) Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides. Neurochem Res 32(11):1957\u20131964. \n                    https:\/\/doi.org\/10.1007\/s11064-007-9394-x","journal-title":"Neurochem Res"},{"key":"1092_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fnagi.2014.00092","volume":"6","author":"GJ Brewer","year":"2014","unstructured":"Brewer GJ (2014) Alzheimer\u2019s disease causation by copper toxicity and treatment with zinc. Front Aging Neurosci 6:92. \n                    https:\/\/doi.org\/10.3389\/fnagi.2014.00092","journal-title":"Front Aging Neurosci"},{"key":"1092_CR32","doi-asserted-by":"publisher","first-page":"971021","DOI":"10.4061\/2011\/971021","volume":"2011","author":"NT Watt","year":"2011","unstructured":"Watt NT, Whitehouse IJ, Hooper NM (2011) The role of zinc in Alzheimer\u2019s disease. Int J Alzheimers Dis 2011:971021. \n                    https:\/\/doi.org\/10.4061\/2011\/971021","journal-title":"Int J Alzheimers Dis"},{"issue":"Suppl 1","key":"1092_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139","author":"AA Belaidi","year":"2016","unstructured":"Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: targets for therapeutics. J Neurochem 139(Suppl 1):179\u2013197. \n                    https:\/\/doi.org\/10.1111\/jnc.13425","journal-title":"J Neurochem"},{"issue":"1","key":"1092_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/jad-2009-1015","volume":"17","author":"A Larbi","year":"2009","unstructured":"Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, Fulop T (2009) Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 17(1):91\u2013103. \n                    https:\/\/doi.org\/10.3233\/jad-2009-1015","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1092_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fimmu.2017.00783","volume":"8","author":"A Page Le","year":"2017","unstructured":"Le Page A, Garneau H, Dupuis G, Frost EH, Larbi A, Witkowski JM, Pawelec G, Fulop T (2017) Differential phenotypes of myeloid-derived suppressor and T regulatory cells and cytokine levels in amnestic mild cognitive impairment subjects compared to mild Alzheimer diseased patients. Front Immunol 8:783. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00783","journal-title":"Front Immunol"},{"key":"1092_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13024-017-0222-8","volume":"12","author":"A Sommer","year":"2017","unstructured":"Sommer A, Winner B, Prots I (2017) The Trojan horse\u2014neuroinflammatory impact of T cells in neurodegenerative diseases. Mol Neurodegener 12:78. \n                    https:\/\/doi.org\/10.1186\/s13024-017-0222-8","journal-title":"Mol Neurodegener"},{"issue":"10","key":"1092_CR37","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanct\u00f4t K, Rothenburg L, Wong A, Cappell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry 68(10):930\u2013941. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2010.06.012","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1092_CR38","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S et al (2017) Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep 7(1):13537. \n                    https:\/\/doi.org\/10.1038\/s41598-017-13601-y","journal-title":"Sci Rep"},{"key":"1092_CR39","doi-asserted-by":"publisher","unstructured":"Zhao Y, Cong L, Jaber V, Lukiw WJ (2017) Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer\u2019s disease brain. Front Immunol 8(1064). \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.01064","DOI":"10.3389\/fimmu.2017.01064"},{"key":"1092_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C (2013) Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21\u201343. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2013.06.004","journal-title":"Prog Neurobiol"},{"issue":"1 Suppl","key":"1092_CR41","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jalz.2013.12.004","volume":"10","author":"FG Felice De","year":"2014","unstructured":"De Felice FG, Lourenco MV, Ferreira ST (2014) How does brain insulin resistance develop in Alzheimer\u2019s disease? Alzheimers Dement 10(1 Suppl):S26\u2013S32. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2013.12.004","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1092_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00005-012-0210-1","volume":"61","author":"V Wieser","year":"2013","unstructured":"Wieser V, Moschen AR, Tilg H (2013) Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp 61(2):119\u2013125. \n                    https:\/\/doi.org\/10.1007\/s00005-012-0210-1","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"1092_CR43","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EC-14-0092","volume":"4","author":"MK Montgomery","year":"2015","unstructured":"Montgomery MK, Turner N (2015) Mitochondrial dysfunction and insulin resistance: an update. Endocrine Connections 4(1):R1\u2013R15. \n                    https:\/\/doi.org\/10.1530\/EC-14-0092","journal-title":"Endocrine Connections"},{"key":"1092_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci 1147:180\u2013195. \n                    https:\/\/doi.org\/10.1196\/annals.1427.007","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"1092_CR45","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2337\/dc09-0259","volume":"32","author":"K Park","year":"2009","unstructured":"Park K, Gross M, Lee D-H, Holvoet P, Himes JH, Shikany JM, Jacobs DR (2009) Oxidative stress and insulin resistance: the Coronary Artery Risk Development in Young Adults study. Diabetes Care 32(7):1302\u20131307. \n                    https:\/\/doi.org\/10.2337\/dc09-0259","journal-title":"Diabetes Care"},{"issue":"6","key":"1092_CR46","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.4049\/jimmunol.1401174","volume":"193","author":"J Nikolich-\u017dugich","year":"2014","unstructured":"Nikolich-\u017dugich J (2014) Aging of the T cell compartment in mice and humans: from no na\u00efve expectations to foggy memories. J Immunol (Baltimore, Md : 1950) 193(6):2622\u20132629. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1401174","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"1","key":"1092_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1567205012666151020114607","volume":"13","author":"E Head","year":"2016","unstructured":"Head E, Lott IT, Wilcock DM, Lemere CA (2016) Aging in down syndrome and the development of Alzheimer\u2019s disease neuropathology. Curr Alzheimer Res 13(1):18\u201329","journal-title":"Curr Alzheimer Res"},{"key":"1092_CR48","doi-asserted-by":"publisher","unstructured":"Cole A (2012) GSK3 as a sensor determining cell fate in the brain. Front Mol Neurosci 5(4). \n                    https:\/\/doi.org\/10.3389\/fnmol.2012.00004","DOI":"10.3389\/fnmol.2012.00004"},{"key":"1092_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4939-2404-2_3","volume":"847","author":"N Martinez-Lopez","year":"2015","unstructured":"Martinez-Lopez N, Athonvarangkul D, Singh R (2015) Autophagy and aging. Adv Exp Med Biol 847:73\u201387. \n                    https:\/\/doi.org\/10.1007\/978-1-4939-2404-2_3","journal-title":"Adv Exp Med Biol"},{"issue":"Supplement C","key":"1092_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neurobiolaging.2016.11.011","volume":"50","author":"KA Josephs","year":"2017","unstructured":"Josephs KA, Tosakulwong N, Weigand SD, Murray ME, Whitwell JL, Parisi JE, Dickson DW, Petersen RC (2017) Brain tau deposition linked to systemic causes of death in normal elderly. Neurobiol Aging 50(Supplement C):163\u2013166. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.11.011","journal-title":"Neurobiol Aging"},{"key":"1092_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neurobiolaging.2016.04.002","volume":"43","author":"L Pirpamer","year":"2016","unstructured":"Pirpamer L, Hofer E, Gesierich B, De Guio F, Freudenberger P, Seiler S, Duering M, Jouvent E et al (2016) Determinants of iron accumulation in the normal aging brain. Neurobiol Aging 43:149\u2013155. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.04.002","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1092_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.chom.2017.03.002","volume":"21","author":"N Thevaranjan","year":"2017","unstructured":"Thevaranjan N, Puchta A, Schulz C, Naidoo A, Szamosi JC, Verschoor CP, Loukov D, Schenck LP et al (2017) Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 21(4):455\u2013466.e454. \n                    https:\/\/doi.org\/10.1016\/j.chom.2017.03.002","journal-title":"Cell Host Microbe"},{"key":"1092_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000346362","volume":"28","author":"A Lim","year":"2013","unstructured":"Lim A, Krajina K, Marsland AL (2013) Peripheral inflammation and cognitive aging. Mod Trends Pharmacopsychiatry 28:175\u2013187. \n                    https:\/\/doi.org\/10.1159\/000346362","journal-title":"Mod Trends Pharmacopsychiatry"},{"key":"1092_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fncel.2012.00038","volume":"6","author":"JM Gemechu","year":"2012","unstructured":"Gemechu JM, Bentivoglio M (2012) T cell recruitment in the brain during normal aging. Front Cell Neurosci 6:38. \n                    https:\/\/doi.org\/10.3389\/fncel.2012.00038","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1092_CR55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1602\/neurorx.1.2.226","volume":"1","author":"MC Irizarry","year":"2004","unstructured":"Irizarry MC (2004) Biomarkers of Alzheimer disease in plasma. NeuroRx 1(2):226\u2013234","journal-title":"NeuroRx"},{"issue":"3","key":"1092_CR56","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G (2012) Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harbor Perspect Med 2(3):a006312. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a006312","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"1092_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3233\/JAD-2008-14107","volume":"14","author":"M Percy","year":"2008","unstructured":"Percy M, Moalem S, Garcia A, Somerville MJ, Hicks M, Andrews D, Azad A, Schwarz P et al (2008) Involvement of ApoE E4 and H63D in sporadic Alzheimer\u2019s disease in a folate-supplemented Ontario population. J Alzheimer\u2019s Dis: JAD 14(1):69\u201384","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1092_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fphar.2014.00165","volume":"5","author":"F Ali-Rahmani","year":"2014","unstructured":"Ali-Rahmani F, Schengrund C-L, Connor JR (2014) HFE gene variants, iron, and lipids: a novel connection in Alzheimer\u2019s disease. Front Pharmacol 5:165. \n                    https:\/\/doi.org\/10.3389\/fphar.2014.00165","journal-title":"Front Pharmacol"},{"issue":"16","key":"1092_CR59","first-page":"1569","volume":"369","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Hardy J (2013) TREM2 and neurodegenerative disease. N Engl J Med 369(16):1569\u20131570","journal-title":"N Engl J Med"},{"key":"1092_CR60","doi-asserted-by":"publisher","unstructured":"Zhong L, Chen X-F, Wang T, Wang Z, Liao C, Wang Z, Huang R, Wang D et al (2017) Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med. \n                    https:\/\/doi.org\/10.1084\/jem.20160844","DOI":"10.1084\/jem.20160844"},{"issue":"7","key":"1092_CR61","doi-asserted-by":"publisher","first-page":"e0177814","DOI":"10.1371\/journal.pone.0177814","volume":"12","author":"D Mastroeni","year":"2017","unstructured":"Mastroeni D, Sekar S, Nolz J, Delvaux E, Lunnon K, Mill J, Liang WS, Coleman PD (2017) ANK1 is up-regulated in laser captured microglia in Alzheimer\u2019s brain; the importance of addressing cellular heterogeneity. PLoS One 12(7):e0177814. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0177814","journal-title":"PLoS One"},{"key":"1092_CR62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fnbeh.2015.00347","volume":"9","author":"JV Sanchez-Mut","year":"2015","unstructured":"Sanchez-Mut JV, Gr\u00e4ff J (2015) Epigenetic alterations in Alzheimer\u2019s disease. Front Behav Neurosci 9:347. \n                    https:\/\/doi.org\/10.3389\/fnbeh.2015.00347","journal-title":"Front Behav Neurosci"},{"issue":"11","key":"1092_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge PG, Mukherjee S, Crane PK, Kauwe JS (2013) Alzheimer\u2019s disease: analyzing the missing heritability. PLoS One 8(11):e79771. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0079771","journal-title":"PLoS One"},{"key":"1092_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2016.07.008","volume":"47","author":"AR Smith","year":"2016","unstructured":"Smith AR, Smith RG, Condliffe D, Hannon E, Schalkwyk L, Mill J, Lunnon K (2016) Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain. Neurobiol Aging 47:35\u201340. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.07.008","journal-title":"Neurobiol Aging"},{"issue":"9","key":"1092_CR65","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, Troakes C, Al-Sarraj S et al (2014) Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci 17(9):1164\u20131170. \n                    https:\/\/doi.org\/10.1038\/nn.3782","journal-title":"Nat Neurosci"},{"key":"1092_CR66","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL Jager De","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, Eaton ML, Keenan BT et al (2014) Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17:1156. \n                    https:\/\/doi.org\/10.1038\/nn.3786\n                    \n                   \n                    https:\/\/www.nature.com\/articles\/nn.3786#supplementary-information","journal-title":"Nat Neurosci"},{"issue":"24","key":"1092_CR67","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1093\/hmg\/ddt354","volume":"22","author":"C-E Yu","year":"2013","unstructured":"Yu C-E, Cudaback E, Foraker J, Thomson Z, Leong L, Lutz F, Gill JA, Saxton A et al (2013) Epigenetic signature and enhancer activity of the human APOE gene. Hum Mol Genet 22(24):5036\u20135047. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt354","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1092_CR68","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3233\/jad-143060","volume":"48","author":"J Foraker","year":"2015","unstructured":"Foraker J, Millard SP, Leong L, Thomson Z, Chen S, Keene CD, Bekris LM, Yu CE (2015) The APOE gene is differentially methylated in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis : JAD 48(3):745\u2013755. \n                    https:\/\/doi.org\/10.3233\/jad-143060","journal-title":"J Alzheimer\u2019s Dis : JAD"},{"key":"1092_CR69","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13148-016-0202-9","volume":"8","author":"N Celarain","year":"2016","unstructured":"Celarain N, Sanchez-Ruiz de Gordoa J, Zelaya MV, Roldan M, Larumbe R, Pulido L, Echavarri C, Mendioroz M (2016) TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer\u2019s disease hippocampus. Clin Epigenetics 8:37. \n                    https:\/\/doi.org\/10.1186\/s13148-016-0202-9","journal-title":"Clin Epigenetics"},{"key":"1092_CR70","doi-asserted-by":"publisher","unstructured":"Lai KSP, Liu CS, Rau A, Lanct\u00f4t KL, K\u00f6hler CA, Pakosh M, Carvalho AF, Herrmann N (2017) Peripheral inflammatory markers in Alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry. \n                    https:\/\/doi.org\/10.1136\/jnnp-2017-316201","DOI":"10.1136\/jnnp-2017-316201"},{"key":"1092_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2012.07.012","volume":"28","author":"C Cunningham","year":"2013","unstructured":"Cunningham C, MacLullich AMJ (2013) At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav Immun 28:1\u201313. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2012.07.012","journal-title":"Brain Behav Immun"},{"issue":"10","key":"1092_CR72","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/wnl.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73(10):768\u2013774. \n                    https:\/\/doi.org\/10.1212\/wnl.0b013e3181b6bb95","journal-title":"Neurology"},{"key":"1092_CR73","doi-asserted-by":"publisher","unstructured":"Chen B, Soto C, Morales R (2014) Corrigendum to \u201cPeripherally administrated prions reach the brain at sub-infectious quantities in experimental hamsters\u201d [FEBS Lett. 588 (2014) 795-800]. FEBS Lett 588 (17):3308\u20133309. doi:\n                    https:\/\/doi.org\/10.1016\/j.febslet.2014.06.039","DOI":"10.1016\/j.febslet.2014.06.039"},{"issue":"2","key":"1092_CR74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/jad-2010-1252","volume":"19","author":"A Politis","year":"2010","unstructured":"Politis A, Olgiati P, Malitas P, Albani D, Signorini A, Polito L, De Mauro S, Zisaki A et al (2010) Vitamin B12 levels in Alzheimer\u2019s disease: association with clinical features and cytokine production. J Alzheimers Dis 19(2):481\u2013488. \n                    https:\/\/doi.org\/10.3233\/jad-2010-1252","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1092_CR75","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1212\/wnl.0b013e318225ae07","volume":"77","author":"C Holmes","year":"2011","unstructured":"Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH (2011) Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 77(3):212\u2013218. \n                    https:\/\/doi.org\/10.1212\/wnl.0b013e318225ae07","journal-title":"Neurology"},{"issue":"6","key":"1092_CR76","first-page":"433","volume":"13","author":"F Jabbari Azad","year":"2014","unstructured":"Jabbari Azad F, Talaei A, Rafatpanah H, Yousefzadeh H, Jafari R, Talaei A, Farid Hosseini R (2014) Association between cytokine production and disease severity in Alzheimer\u2019s disease. Iran J Allergy Asthma Immunol 13(6):433\u2013439","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"1092_CR77","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jalz.2010.05.178","volume":"6","author":"S Lovestone","year":"2010","unstructured":"Lovestone S, Simmons A (2010) Combinatorial markers of MCI conversion: cytokines and MRI measures together predict disease progression. Alzheimers Dement 6(4):S62. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2010.05.178","journal-title":"Alzheimers Dement"},{"issue":"Suppl 3","key":"1092_CR78","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/jad-2011-0044","volume":"26","author":"SJ Furney","year":"2011","unstructured":"Furney SJ, Kronenberg D, Simmons A, Guntert A, Dobson RJ, Proitsi P, Wahlund LO, Kloszewska I et al (2011) Combinatorial markers of mild cognitive impairment conversion to Alzheimer\u2019s disease\u2014cytokines and MRI measures together predict disease progression. J Alzheimer\u2019s Dis: JAD 26(Suppl 3):395\u2013405. \n                    https:\/\/doi.org\/10.3233\/jad-2011-0044","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"3","key":"1092_CR79","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/nmm:7:3:255","volume":"7","author":"T Town","year":"2005","unstructured":"Town T, Tan J, Flavell RA, Mullan M (2005) T-cells in Alzheimer\u2019s disease. NeuroMolecular Med 7(3):255\u2013264. \n                    https:\/\/doi.org\/10.1385\/nmm:7:3:255","journal-title":"NeuroMolecular Med"},{"key":"1092_CR80","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/ni.3427","volume":"17","author":"Z Fehervari","year":"2016","unstructured":"Fehervari Z (2016) Lymphocytes in Alzheimer's disease. Nat Immunol 17:355. \n                    https:\/\/doi.org\/10.1038\/ni.3427","journal-title":"Nat Immunol"},{"issue":"1\u20132","key":"1092_CR81","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jneuroim.2011.11.005","volume":"242","author":"M Pellicano","year":"2012","unstructured":"Pellicano M, Larbi A, Goldeck D, Colonna-Romano G, Buffa S, Bulati M, Rubino G, Iemolo F et al (2012) Immune profiling of Alzheimer patients. J Neuroimmunol 242(1\u20132):52\u201359. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2011.11.005","journal-title":"J Neuroimmunol"},{"key":"1092_CR82","doi-asserted-by":"publisher","unstructured":"Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Alberoni M, Nemni R, Clerici M (2011) Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease. Brain Behav Immun 25(3):539\u2013547. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2010.12.004","DOI":"10.1016\/j.bbi.2010.12.004"},{"issue":"1","key":"1092_CR83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2014.08.008","volume":"36","author":"G Lueg","year":"2015","unstructured":"Lueg G, Gross CC, Lohmann H, Johnen A, Kemmling A, Deppe M, Groger J, Minnerup J et al (2015) Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer\u2019s disease. Neurobiol Aging 36(1):81\u201389. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.08.008","journal-title":"Neurobiol Aging"},{"issue":"supplement C","key":"1092_CR84","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2016.06.014","volume":"68","author":"S D\u00e1 Mesquita","year":"2016","unstructured":"D\u00e1 Mesquita S, Ferreira AC, Sousa JC, Correia-Neves M, Sousa N, Marques F (2016) Insights on the pathophysiology of Alzheimer\u2019s disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system. Neurosci Biobehav Rev 68(supplement C):547\u2013562. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2016.06.014","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"1092_CR85","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2174\/1567205013666151116124912","volume":"13","author":"N Esteras","year":"2016","unstructured":"Esteras N, Alquezar C, de la Encarnacion A, Martin-Requero A (2016) Lymphocytes in Alzheimer\u2019s disease pathology: altered signaling pathways. Curr Alzheimer Res 13(4):439\u2013449","journal-title":"Curr Alzheimer Res"},{"issue":"supplement C","key":"1092_CR86","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbi.2016.02.009","volume":"54","author":"MT Ferretti","year":"2016","unstructured":"Ferretti MT, Merlini M, Sp\u00e4ni C, Gericke C, Schweizer N, Enzmann G, Engelhardt B, Kulic L et al (2016) T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer\u2019s disease-like cerebral amyloidosis. Brain Behav Immun 54(supplement C):211\u2013225. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2016.02.009","journal-title":"Brain Behav Immun"},{"issue":"4","key":"1092_CR87","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3233\/jad-161304","volume":"58","author":"M Busse","year":"2017","unstructured":"Busse M, Michler E, von Hoff F, Dobrowolny H, Hartig R, Frodl T, Busse S (2017) Alterations in the peripheral immune system in dementia. Journal of Alzheimer\u2019s disease : JAD 58(4):1303\u20131313. \n                    https:\/\/doi.org\/10.3233\/jad-161304","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"issue":"supplement C","key":"1092_CR88","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coph.2015.10.003","volume":"26","author":"KJ Bryson","year":"2016","unstructured":"Bryson KJ, Lynch MA (2016) Linking T cells to Alzheimer\u2019s disease: from neurodegeneration to neurorepair. Curr Opin Pharmacol 26(supplement C):67\u201373. \n                    https:\/\/doi.org\/10.1016\/j.coph.2015.10.003","journal-title":"Curr Opin Pharmacol"},{"issue":"7","key":"1092_CR89","doi-asserted-by":"publisher","first-page":"e68996","DOI":"10.1371\/journal.pone.0068996","volume":"8","author":"M Maftei","year":"2013","unstructured":"Maftei M, Thurm F, Schnack C, Tumani H, Otto M, Elbert T, Kolassa I-T, Przybylski M et al (2013) Increased levels of antigen-bound \u03b2-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer\u2019s disease patients. PLoS One 8(7):e68996. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0068996","journal-title":"PLoS One"},{"issue":"1","key":"1092_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/jad-150236","volume":"48","author":"S Sollvander","year":"2015","unstructured":"Sollvander S, Ekholm-Pettersson F, Brundin RM, Westman G, Kilander L, Paulie S, Lannfelt L, Sehlin D (2015) Increased number of plasma B cells producing autoantibodies against Abeta42 protofibrils in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 48(1):63\u201372. \n                    https:\/\/doi.org\/10.3233\/jad-150236","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1092_CR91","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainres.2008.02.060","volume":"1219","author":"W Xu","year":"2008","unstructured":"Xu W, Kawarabayashi T, Matsubara E, Deguchi K, Murakami T, Harigaya Y, Ikeda M, Amari M et al (2008) Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer\u2019s disease and normal controls. Brain Res 1219:169\u2013179. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2008.02.060","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"1092_CR92","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/s10875-010-9414-5","volume":"30","author":"S Paul","year":"2010","unstructured":"Paul S, Planque S, Nishiyama Y (2010) Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide. J Clin Immunol 30(Suppl 1):S43\u2013S49. \n                    https:\/\/doi.org\/10.1007\/s10875-010-9414-5","journal-title":"J Clin Immunol"},{"issue":"5","key":"1092_CR93","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2008.03.004","volume":"7","author":"H Taguchi","year":"2008","unstructured":"Taguchi H, Planque S, Nishiyama Y, Szabo P, Weksler ME, Friedland RP, Paul S (2008) Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun Rev 7(5):391\u2013397. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2008.03.004","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1092_CR94","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2003.10.071","volume":"355","author":"L Baril","year":"2004","unstructured":"Baril L, Nicolas L, Croisile B, Crozier P, Hessler C, Sassolas A, McCormick JB, Trannoy E (2004) Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer\u2019s disease and control subjects. Neurosci Lett 355(3):226\u2013230","journal-title":"Neurosci Lett"},{"issue":"40","key":"1092_CR95","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.2174\/1381612822666160914182822","volume":"22","author":"G Morris","year":"2016","unstructured":"Morris G, Berk M, Carvalho AF, Caso JR, Sanz Y, Maes M (2016) The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimmune processes with an emphasis on inflammatory bowel disease type 1 diabetes and chronic fatigue syndrome. Curr Pharm Des 22(40):6058\u20136075","journal-title":"Curr Pharm Des"},{"key":"1092_CR96","doi-asserted-by":"publisher","unstructured":"Morris G, Berk M, Carvalho A, Caso JR, Sanz Y, Walder K, Maes M (2016) The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-016-0004-2","DOI":"10.1007\/s12035-016-0004-2"},{"issue":"11","key":"1092_CR97","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.it.2010.08.005","volume":"31","author":"JP McAleer","year":"2010","unstructured":"McAleer JP, Vella AT (2010) Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends Immunol 31(11):429\u2013435. \n                    https:\/\/doi.org\/10.1016\/j.it.2010.08.005","journal-title":"Trends Immunol"},{"issue":"2","key":"1092_CR98","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2567.2008.02832.x","volume":"125","author":"H Xu","year":"2008","unstructured":"Xu H, Liew LN, Kuo IC, Huang CH, Goh DL-M, Chua KY (2008) The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization. Immunology 125(2):218\u2013228. \n                    https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02832.x","journal-title":"Immunology"},{"issue":"9","key":"1092_CR99","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1002\/eji.200738094","volume":"38","author":"S Minguet","year":"2008","unstructured":"Minguet S, Dopfer EP, Pollmer C, Freudenberg MA, Galanos C, Reth M, Huber M, Schamel WW (2008) Enhanced B-cell activation mediated by TLR4 and BCR crosstalk. Eur J Immunol 38(9):2475\u20132487. \n                    https:\/\/doi.org\/10.1002\/eji.200738094","journal-title":"Eur J Immunol"},{"issue":"32","key":"1092_CR100","doi-asserted-by":"publisher","first-page":"13064","DOI":"10.1073\/pnas.1120585109","volume":"109","author":"JM Reynolds","year":"2012","unstructured":"Reynolds JM, Martinez GJ, Chung Y, Dong C (2012) Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci U S A 109(32):13064\u201313069. \n                    https:\/\/doi.org\/10.1073\/pnas.1120585109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1092_CR101","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.4049\/jimmunol.1302569","volume":"192","author":"W Cui","year":"2014","unstructured":"Cui W, Joshi NS, Liu Y, Meng H, Kleinstein SH, Kaech SM (2014) TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T cell differentiation. J Immunol (Baltimore, Md : 1950) 192(9):4221\u20134232. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1302569","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"9","key":"1092_CR102","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.4049\/jimmunol.0803616","volume":"182","author":"JP McAleer","year":"2009","unstructured":"McAleer JP, Rossi RJ, Vella AT (2009) Lipopolysaccharide potentiates effector T cell accumulation into non-lymphoid tissues through TRIF. J Immunol (Baltimore, Md : 1950) 182(9):5322\u20135330. \n                    https:\/\/doi.org\/10.4049\/jimmunol.0803616","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"6","key":"1092_CR103","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/eji.200838866","volume":"39","author":"M Komai-Koma","year":"2009","unstructured":"Komai-Koma M, Gilchrist DS, Xu D (2009) Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex. Eur J Immunol 39(6):1564\u20131572. \n                    https:\/\/doi.org\/10.1002\/eji.200838866","journal-title":"Eur J Immunol"},{"issue":"1","key":"1092_CR104","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s41598-017-01033-7","volume":"7","author":"A Tripathy","year":"2017","unstructured":"Tripathy A, Khanna S, Padhan P, Smita S, Raghav S, Gupta B (2017) Direct recognition of LPS drive TLR4 expressing CD8(+) T cell activation in patients with rheumatoid arthritis. Sci Rep 7(1):933. \n                    https:\/\/doi.org\/10.1038\/s41598-017-01033-7","journal-title":"Sci Rep"},{"key":"1092_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fimmu.2013.00011","volume":"4","author":"LM Kanevskiy","year":"2013","unstructured":"Kanevskiy LM, Telford WG, Sapozhnikov AM, Kovalenko EI (2013) Lipopolysaccharide induces IFN-\u03b3 production in human NK cells. Front Immunol 4:11. \n                    https:\/\/doi.org\/10.3389\/fimmu.2013.00011","journal-title":"Front Immunol"},{"issue":"1","key":"1092_CR106","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4049\/jimmunol.165.1.139","volume":"165","author":"MR Goodier","year":"2000","unstructured":"Goodier MR, Londei M (2000) Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. J Immunol (Baltimore, Md : 1950) 165(1):139\u2013147","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"4","key":"1092_CR107","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0306-4530(01)00062-2","volume":"27","author":"RG Masera","year":"2002","unstructured":"Masera RG, Prolo P, Sartori ML, Staurenghi A, Griot G, Ravizza L, Dovio A, Chiappelli F et al (2002) Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer\u2019s disease. Psychoneuroendocrinology 27(4):447\u2013461","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"1092_CR108","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-3083.2012.02769.x","volume":"76","author":"F Jadidi-Niaragh","year":"2012","unstructured":"Jadidi-Niaragh F, Shegarfi H, Naddafi F, Mirshafiey A (2012) The role of natural killer cells in Alzheimer\u2019s disease. Scand J Immunol 76(5):451\u2013456. \n                    https:\/\/doi.org\/10.1111\/j.1365-3083.2012.02769.x","journal-title":"Scand J Immunol"},{"issue":"1\u20133","key":"1092_CR109","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbrc.2007.03.150","volume":"357","author":"L Jofre-Monseny","year":"2007","unstructured":"Jofre-Monseny L, Loboda A, Wagner AE, Huebbe P, Boesch-Saadatmandi C, Jozkowicz A, Minihane A-M, Dulak J et al (2007) Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Commun 357(1\u20133):319\u2013324. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2007.03.150","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1092_CR110","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/mnfr.200900398","volume":"54","author":"P Huebbe","year":"2010","unstructured":"Huebbe P, Lodge JK, Rimbach G (2010) Implications of apolipoprotein E genotype on inflammation and vitamin E status. Mol Nutr Food Res 54(5):623\u2013630. \n                    https:\/\/doi.org\/10.1002\/mnfr.200900398","journal-title":"Mol Nutr Food Res"},{"issue":"33","key":"1092_CR111","doi-asserted-by":"publisher","first-page":"27876","DOI":"10.1074\/jbc.M112.377549","volume":"287","author":"JG Cash","year":"2012","unstructured":"Cash JG, Kuhel DG, Basford JE, Jaeschke A, Chatterjee TK, Weintraub NL, Hui DY (2012) Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress. J Biol Chem 287(33):27876\u201327884. \n                    https:\/\/doi.org\/10.1074\/jbc.M112.377549","journal-title":"J Biol Chem"},{"key":"1092_CR112","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-319-39406-0_2","volume":"930","author":"AM Fond","year":"2016","unstructured":"Fond AM, Ravichandran KS (2016) Clearance of dying cells by phagocytes: mechanisms and implications for disease pathogenesis. Adv Exp Med Biol 930:25\u201349. \n                    https:\/\/doi.org\/10.1007\/978-3-319-39406-0_2","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1092_CR113","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2008.08.009","volume":"29","author":"JA Hall","year":"2008","unstructured":"Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, Grigg ME, Berzofsky JA et al (2008) Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29(4):637\u2013649. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2008.08.009","journal-title":"Immunity"},{"issue":"4","key":"1092_CR114","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.chom.2012.09.009","volume":"12","author":"I Ivanov Ivaylo","year":"2012","unstructured":"Ivanov Ivaylo I, Honda K (2012) Intestinal commensal microbes as immune modulators. Cell Host Microbe 12(4):496\u2013508. \n                    https:\/\/doi.org\/10.1016\/j.chom.2012.09.009","journal-title":"Cell Host Microbe"},{"key":"1092_CR115","doi-asserted-by":"crossref","unstructured":"Atarashi K, Honda K (2008) Analysis of murine lamina propria TH17 cells.","DOI":"10.1038\/nprot.2008.205"},{"key":"1092_CR116","doi-asserted-by":"publisher","unstructured":"Kumar H, Lund R, Laiho A, Lundelin K, Ley RE, Isolauri E, Salminen S (2014) Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 5(6). \n                    https:\/\/doi.org\/10.1128\/mBio.02113-14","DOI":"10.1128\/mBio.02113-14"},{"issue":"5","key":"1092_CR117","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10620-017-4538-6","volume":"62","author":"J Ye","year":"2017","unstructured":"Ye J, Wu W, Li Y, Li L (2017) Influences of the gut microbiota on DNA methylation and histone modification. Dig Dis Sci 62(5):1155\u20131164. \n                    https:\/\/doi.org\/10.1007\/s10620-017-4538-6","journal-title":"Dig Dis Sci"},{"key":"1092_CR118","doi-asserted-by":"publisher","first-page":"29353","DOI":"10.1038\/srep29353","volume":"6","author":"D Saita","year":"2016","unstructured":"Saita D, Ferrarese R, Foglieni C, Esposito A, Canu T, Perani L, Ceresola ER, Visconti L et al (2016) Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation. Sci Rep 6:29353. \n                    https:\/\/doi.org\/10.1038\/srep29353\n                    \n                   \n                    https:\/\/www.nature.com\/articles\/srep29353#supplementary-information","journal-title":"Sci Rep"},{"key":"1092_CR119","doi-asserted-by":"publisher","unstructured":"Song J, Lee JE (2015) miR-155 is involved in Alzheimer\u2019s disease by regulating T lymphocyte function. Frontiers in aging neuroscience 7:61. doi:\n                    https:\/\/doi.org\/10.3389\/fnagi.2015.00061","DOI":"10.3389\/fnagi.2015.00061"},{"issue":"15","key":"1092_CR120","doi-asserted-by":"publisher","first-page":"19089","DOI":"10.18632\/oncotarget.7862","volume":"7","author":"H Li","year":"2016","unstructured":"Li H, Guo Z, Guo Y, Li M, Yan H, Cheng J, Wang C, Hong G (2016) Common DNA methylation alterations of Alzheimer\u2019s disease and aging in peripheral whole blood. Oncotarget 7(15):19089\u201319098. \n                    https:\/\/doi.org\/10.18632\/oncotarget.7862","journal-title":"Oncotarget"},{"issue":"1","key":"1092_CR121","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","volume":"50","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ (2014) Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer\u2019s disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol 50(1):97\u2013106. \n                    https:\/\/doi.org\/10.1007\/s12035-013-8595-3","journal-title":"Mol Neurobiol"},{"issue":"9","key":"1092_CR122","first-page":"1764","volume":"20","author":"Y Yang","year":"2016","unstructured":"Yang Y, Wang JK (2016) The functional analysis of microRNAs involved in NF-kappaB signaling. Eur Rev Med Pharmacol Sci 20(9):1764\u20131774","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1092_CR123","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4172\/1948-5948.1000276","volume":"8","author":"AR Naqvi","year":"2016","unstructured":"Naqvi AR, Zhong S, Dang H, Fordham JB, Nares S, Khan A (2016) Expression profiling of LPS responsive miRNA in primary human macrophages. J Microb Biochem Technol 8(2):136\u2013143. \n                    https:\/\/doi.org\/10.4172\/1948-5948.1000276","journal-title":"J Microb Biochem Technol"},{"issue":"19","key":"1092_CR124","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87748","volume":"1","author":"X Wang","year":"2016","unstructured":"Wang X, Cao Q, Yu L, Shi H, Xue B, Shi H (2016) Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity. JCI Insight 1(19):e87748. \n                    https:\/\/doi.org\/10.1172\/jci.insight.87748","journal-title":"JCI Insight"},{"issue":"1","key":"1092_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.04.295","volume":"241","author":"S Czauderna","year":"2015","unstructured":"Czauderna S, Rudnik M, Losko M, Witalisz A, Jozkowicz A, Dulak J, Loboda A (2015) Influence of apolipoprotein E isoform on microRNA transcriptome in macrophages. Atherosclerosis 241(1):e84. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.04.295","journal-title":"Atherosclerosis"},{"issue":"4","key":"1092_CR126","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1210\/me.2013-1293","volume":"28","author":"X Yang","year":"2014","unstructured":"Yang X, Wang X, Liu D, Yu L, Xue B, Shi H (2014) Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Mol Endocrinol 28(4):565\u2013574. \n                    https:\/\/doi.org\/10.1210\/me.2013-1293","journal-title":"Mol Endocrinol"},{"issue":"2","key":"1092_CR127","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/shk.0000000000000604","volume":"46","author":"K Essandoh","year":"2016","unstructured":"Essandoh K, Li Y, Huo J, Fan GC (2016) MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock (Augusta, Ga) 46(2):122\u2013131. \n                    https:\/\/doi.org\/10.1097\/shk.0000000000000604","journal-title":"Shock (Augusta, Ga)"},{"issue":"1","key":"1092_CR128","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","volume":"8","author":"M Mann","year":"2017","unstructured":"Mann M, Mehta A, Zhao JL, Lee K, Marinov GK, Garcia-Flores Y, Baltimore D (2017) An NF-\u03baB-microRNA regulatory network tunes macrophage inflammatory responses. Nat Commun 8(1):851. \n                    https:\/\/doi.org\/10.1038\/s41467-017-00972-z","journal-title":"Nat Commun"},{"key":"1092_CR129","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fneur.2014.00181","volume":"5","author":"PN Alexandrov","year":"2014","unstructured":"Alexandrov PN, Dua P, Lukiw WJ (2014) Up-regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS. Front Neurol 5:181. \n                    https:\/\/doi.org\/10.3389\/fneur.2014.00181","journal-title":"Front Neurol"},{"issue":"1","key":"1092_CR130","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/eji.201141679","volume":"42","author":"H Ito","year":"2012","unstructured":"Ito H, Hamerman JA (2012) TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol 42(1):176\u2013185. \n                    https:\/\/doi.org\/10.1002\/eji.201141679","journal-title":"Eur J Immunol"},{"issue":"1","key":"1092_CR131","doi-asserted-by":"publisher","first-page":"11853","DOI":"10.1038\/s41598-017-12330-6","volume":"7","author":"SC Hall","year":"2017","unstructured":"Hall SC, Agrawal DK (2017) Increased TREM-2 expression on the subsets of CD11c+ cells in the lungs and lymph nodes during allergic airway inflammation. Sci Rep 7(1):11853. \n                    https:\/\/doi.org\/10.1038\/s41598-017-12330-6","journal-title":"Sci Rep"},{"issue":"43","key":"1092_CR132","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey CC, DeVaux LB, Farzan M (2015) The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E. J Biol Chem 290(43):26033\u201326042. \n                    https:\/\/doi.org\/10.1074\/jbc.M115.677286","journal-title":"J Biol Chem"},{"key":"1092_CR133","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpsychires.2017.04.003","volume":"92","author":"Y Ozaki","year":"2017","unstructured":"Ozaki Y, Yoshino Y, Yamazaki K, Sao T, Mori Y, Ochi S, Yoshida T, Mori T et al (2017) DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer\u2019s disease. J Psychiatr Res 92:74\u201380. \n                    https:\/\/doi.org\/10.1016\/j.jpsychires.2017.04.003","journal-title":"J Psychiatr Res"},{"issue":"9","key":"1092_CR134","doi-asserted-by":"publisher","first-page":"e0136835","DOI":"10.1371\/journal.pone.0136835","volume":"10","author":"Y Mori","year":"2015","unstructured":"Mori Y, Yoshino Y, Ochi S, Yamazaki K, Kawabe K, Abe M, Kitano T, Ozaki Y et al (2015) TREM2 mRNA expression in leukocytes is increased in Alzheimer\u2019s disease and schizophrenia. PLoS One 10(9):e0136835. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0136835","journal-title":"PLoS One"},{"issue":"2","key":"1092_CR135","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/jad-161277","volume":"58","author":"YJ Tan","year":"2017","unstructured":"Tan YJ, Ng ASL, Vipin A, Lim JKW, Chander RJ, Ji F, Qiu Y, Ting SKS et al (2017) Higher peripheral TREM2 mRNA levels relate to cognitive deficits and hippocampal atrophy in Alzheimer\u2019s disease and amnestic mild cognitive impairment. J Alzheimer\u2019s Dis: JAD 58(2):413\u2013423. \n                    https:\/\/doi.org\/10.3233\/jad-161277","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"3","key":"1092_CR136","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/biom5031284","volume":"5","author":"L Sun","year":"2015","unstructured":"Sun L, Pappy Ii AL, Pham TT, Shanley TP (2015) Study of protein phosphatase 2A (PP2A) activity in LPS-induced tolerance using fluorescence-based and immunoprecipitation-aided methodology. Biomol Ther 5(3):1284\u20131301. \n                    https:\/\/doi.org\/10.3390\/biom5031284","journal-title":"Biomol Ther"},{"issue":"8","key":"1092_CR137","doi-asserted-by":"publisher","first-page":"e0137177","DOI":"10.1371\/journal.pone.0137177","volume":"10","author":"Y-F Chuang","year":"2015","unstructured":"Chuang Y-F, Chen M-C, Huang S-W, Hsu Y-F, Ou G, Tsai Y-J, Hsu M-J (2015) Protein phosphatase 2A in lipopolysaccharide-induced cyclooxygenase-2 expression in murine lymphatic endothelial cells. PLoS One 10(8):e0137177. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0137177","journal-title":"PLoS One"},{"issue":"1","key":"1092_CR138","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12916-014-0259-2","volume":"13","author":"G Morris","year":"2015","unstructured":"Morris G, Berk M, Walder K, Maes M (2015) Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med 13(1):28","journal-title":"BMC Med"},{"key":"1092_CR139","doi-asserted-by":"publisher","unstructured":"Morris G, Walker AJ, Berk M, Maes M, Puri BK (2017) Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-017-0793-y","DOI":"10.1007\/s12035-017-0793-y"},{"key":"1092_CR140","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-014-0142-6","volume":"2","author":"WJ Streit","year":"2014","unstructured":"Streit WJ, Xue Q-S, Tischer J, Bechmann I (2014) Microglial pathology. Acta Neuropathol Commun 2:142. \n                    https:\/\/doi.org\/10.1186\/s40478-014-0142-6","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"1092_CR141","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/brain\/awx120","volume":"140","author":"P Parbo","year":"2017","unstructured":"Parbo P, Ismail R, Hansen KV, Amidi A, Marup FH, Gottrup H, Braendgaard H, Eriksson BO et al (2017) Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer\u2019s disease. Brain 140(7):2002\u20132011. \n                    https:\/\/doi.org\/10.1093\/brain\/awx120","journal-title":"Brain"},{"key":"1092_CR142","doi-asserted-by":"publisher","unstructured":"Solito E, Sastre M (2012) Microglia function in Alzheimer\u2019s disease. Front Pharmacol 3. \n                    https:\/\/doi.org\/10.3389\/fphar.2012.00014","DOI":"10.3389\/fphar.2012.00014"},{"issue":"4","key":"1092_CR143","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-013-1182-x","volume":"126","author":"S Prokop","year":"2013","unstructured":"Prokop S, Miller KR, Heppner FL (2013) Microglia actions in Alzheimer\u2019s disease. Acta Neuropathol 126(4):461\u2013477. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1182-x","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1092_CR144","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1742-2094-11-48","volume":"11","author":"D Doens","year":"2014","unstructured":"Doens D, Fern\u00e1ndez PL (2014) Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation 11(1):48. \n                    https:\/\/doi.org\/10.1186\/1742-2094-11-48","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1092_CR145","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nri2015","volume":"7","author":"VH Perry","year":"2007","unstructured":"Perry VH, Cunningham C, Holmes C (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7(2):161\u2013167. \n                    https:\/\/doi.org\/10.1038\/nri2015","journal-title":"Nat Rev Immunol"},{"issue":"(Pt a","key":"1092_CR146","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuropharm.2014.10.028","volume":"96","author":"DM Norden","year":"2015","unstructured":"Norden DM, Muccigrosso MM, Godbout JP (2015) Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease. Neuropharmacology 96((Pt a):29\u201341. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2014.10.028","journal-title":"Neuropharmacology"},{"key":"1092_CR147","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fnhum.2016.00398","volume":"10","author":"L Hoeijmakers","year":"2016","unstructured":"Hoeijmakers L, Heinen Y, van Dam A-M, Lucassen PJ, Korosi A (2016) Microglial priming and Alzheimer\u2019s disease: a possible role for (early) immune challenges and epigenetics? Front Hum Neurosci 10:398. \n                    https:\/\/doi.org\/10.3389\/fnhum.2016.00398","journal-title":"Front Hum Neurosci"},{"key":"1092_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/576383","volume":"2013","author":"A Boutajangout","year":"2013","unstructured":"Boutajangout A, Wisniewski T (2013) The innate immune system in Alzheimer\u2019s disease. Int J Cell Biol 2013:1\u20137. \n                    https:\/\/doi.org\/10.1155\/2013\/576383","journal-title":"Int J Cell Biol"},{"issue":"2","key":"1092_CR149","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/nejmoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368(2):117\u2013127. \n                    https:\/\/doi.org\/10.1056\/nejmoa1211851","journal-title":"N Engl J Med"},{"issue":"4","key":"1092_CR150","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bpa.12190","volume":"25","author":"L-F Lue","year":"2014","unstructured":"Lue L-F, Schmitz CT, Serrano G, Sue LI, Beach TG, Walker DG (2014) TREM2 protein expression changes correlate with Alzheimer\u2019s disease neurodegenerative pathologies in post-mortem temporal cortices. Brain Pathol 25(4):469\u2013480. \n                    https:\/\/doi.org\/10.1111\/bpa.12190","journal-title":"Brain Pathol"},{"issue":"4","key":"1092_CR151","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","volume":"88","author":"SE Hickman","year":"2014","unstructured":"Hickman SE, El Khoury J (2014) TREM2 and the neuroimmunology of Alzheimer\u2019s disease. Biochem Pharmacol 88(4):495\u2013498. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2013.11.021","journal-title":"Biochem Pharmacol"},{"key":"1092_CR152","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuroscience.2014.09.050","volume":"302","author":"LF Lue","year":"2015","unstructured":"Lue LF, Schmitz C, Walker DG (2015) What happens to microglial TREM2 in Alzheimer\u2019s disease: immunoregulatory turned into immunopathogenic? Neuroscience 302:138\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2014.09.050","journal-title":"Neuroscience"},{"issue":"1","key":"1092_CR153","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","volume":"12","author":"TR Jay","year":"2017","unstructured":"Jay TR, von Saucken VE, Landreth GE (2017) TREM2 in neurodegenerative diseases. Mol Neurodegener 12(1):56. \n                    https:\/\/doi.org\/10.1186\/s13024-017-0197-5","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1092_CR154","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O'Loughlin E et al (2017) The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47(3):566\u2013581.e569. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008","journal-title":"Immunity"},{"issue":"5","key":"1092_CR155","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1096\/fj.14-262683","volume":"29","author":"X Li","year":"2015","unstructured":"Li X, Montine KS, Keene CD, Montine TJ (2015) Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia. FASEB J 29(5):1754\u20131762. \n                    https:\/\/doi.org\/10.1096\/fj.14-262683","journal-title":"FASEB J"},{"issue":"25","key":"1092_CR156","doi-asserted-by":"publisher","first-page":"15866","DOI":"10.1074\/jbc.M115.645986","volume":"290","author":"L Zhong","year":"2015","unstructured":"Zhong L, Chen X-F, Zhang Z-L, Wang Z, Shi X-Z, Xu K, Zhang Y-W, Xu H et al (2015) DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response. J Biol Chem 290(25):15866\u201315877. \n                    https:\/\/doi.org\/10.1074\/jbc.M115.645986","journal-title":"J Biol Chem"},{"issue":"4","key":"1092_CR157","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10048-015-0451-3","volume":"16","author":"A Sasaki","year":"2015","unstructured":"Sasaki A, Kakita A, Yoshida K, Konno T, Ikeuchi T, Hayashi S, Matsuo H, Shioda K (2015) Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease. Neurogenetics 16(4):265\u2013276. \n                    https:\/\/doi.org\/10.1007\/s10048-015-0451-3","journal-title":"Neurogenetics"},{"key":"1092_CR158","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnagi.2017.00204","volume":"9","author":"L Zhong","year":"2017","unstructured":"Zhong L, Zhang ZL, Li X, Liao C, Mou P, Wang T, Wang Z, Wang Z et al (2017) TREM2\/DAP12 complex regulates inflammatory responses in microglia via the JNK signaling pathway. Front Aging Neurosci 9:204. \n                    https:\/\/doi.org\/10.3389\/fnagi.2017.00204","journal-title":"Front Aging Neurosci"},{"issue":"43","key":"1092_CR159","doi-asserted-by":"publisher","first-page":"11138","DOI":"10.1523\/jneurosci.1238-16.2016","volume":"36","author":"M Kobayashi","year":"2016","unstructured":"Kobayashi M, Konishi H, Sayo A, Takai T, Kiyama H (2016) TREM2\/DAP12 signal elicits proinflammatory response in microglia and exacerbates neuropathic pain. J Neurosci 36(43):11138\u201311150. \n                    https:\/\/doi.org\/10.1523\/jneurosci.1238-16.2016","journal-title":"J Neurosci"},{"issue":"46","key":"1092_CR160","doi-asserted-by":"publisher","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid Cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage. J Biol Chem 288(46):33027\u201333036. \n                    https:\/\/doi.org\/10.1074\/jbc.M113.517540","journal-title":"J Biol Chem"},{"issue":"4","key":"1092_CR161","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-016-1612-7","volume":"132","author":"H-U Klein","year":"2016","unstructured":"Klein H-U, Bennett DA, De Jager PL (2016) The epigenome in Alzheimer\u2019s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol 132(4):503\u2013514. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1612-7","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1092_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.91","volume":"7","author":"AE Hall","year":"2016","unstructured":"Hall AE, Lu WT, Godfrey JD, Antonov AV, Paicu C, Moxon S, Dalmay T, Wilczynska A et al (2016) The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration. Cell Death Dis 7(4):e2184. \n                    https:\/\/doi.org\/10.1038\/cddis.2016.91","journal-title":"Cell Death Dis"},{"issue":"4","key":"1092_CR163","doi-asserted-by":"publisher","first-page":"e60436","DOI":"10.1371\/journal.pone.0060436","volume":"8","author":"V Lulli","year":"2013","unstructured":"Lulli V, Romania P, Morsilli O, Cianciulli P, Gabbianelli M, Testa U, Giuliani A, Marziali G (2013) MicroRNA-486-3p regulates gamma-globin expression in human erythroid cells by directly modulating BCL11A. PLoS One 8(4):e60436. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0060436","journal-title":"PLoS One"},{"key":"1092_CR164","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2017.09.038","volume":"410","author":"M Tessema","year":"2017","unstructured":"Tessema M, Yingling CM, Picchi MA, Wu G, Ryba T, Lin Y, Bungum AO, Edell ES et al (2017) ANK1 methylation regulates expression of microRNA-486-5p and discriminates lung tumors by histology and smoking status. Cancer Lett 410:191\u2013200. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2017.09.038","journal-title":"Cancer Lett"},{"key":"1092_CR165","doi-asserted-by":"publisher","first-page":"28006","DOI":"10.1038\/srep28006","volume":"6","author":"S Caserta","year":"2016","unstructured":"Caserta S, Kern F, Cohen J, Drage S, Newbury SF, Llewelyn MJ (2016) Circulating plasma microRNAs can differentiate human sepsis and systemic inflammatory response syndrome (SIRS). Sci Rep 6:28006. \n                    https:\/\/doi.org\/10.1038\/srep28006","journal-title":"Sci Rep"},{"issue":"4","key":"1092_CR166","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3892\/or.2015.4141","volume":"34","author":"J Zhu","year":"2015","unstructured":"Zhu J, Zeng Y, Xu C, Qin H, Lei Z, Shen D, Liu Z, Huang JA (2015) Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer. Oncol Rep 34(4):1779\u20131786. \n                    https:\/\/doi.org\/10.3892\/or.2015.4141","journal-title":"Oncol Rep"},{"issue":"4","key":"1092_CR167","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3892\/ol.2016.4914","volume":"12","author":"RA Youness","year":"2016","unstructured":"Youness RA, El-Tayebi HM, Assal RA, Hosny K, Esmat G, Abdelaziz AI (2016) MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc. Oncol Lett 12(4):2567\u20132573. \n                    https:\/\/doi.org\/10.3892\/ol.2016.4914","journal-title":"Oncol Lett"},{"issue":"1","key":"1092_CR168","doi-asserted-by":"publisher","first-page":"11776","DOI":"10.1038\/s41598-017-10407-w","volume":"7","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wang Y, Yao A, Xu Z, Dou H, Shen S, Hou Y, Wang T (2017) Low frequency magnetic fields induce autophagy-associated cell death in lung cancer through miR-486-mediated inhibition of Akt\/mTOR signaling pathway. Sci Rep 7(1):11776. \n                    https:\/\/doi.org\/10.1038\/s41598-017-10407-w","journal-title":"Sci Rep"},{"issue":"9","key":"1092_CR169","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.bcp.2009.06.097","volume":"78","author":"C Russo Dello","year":"2009","unstructured":"Dello Russo C, Lisi L, Tringali G, Navarra P (2009) Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochem Pharmacol 78(9):1242\u20131251. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2009.06.097","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1092_CR170","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","volume":"198","author":"E Vergadi","year":"2017","unstructured":"Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C (2017) Akt signaling pathway in macrophage activation and M1\/M2 polarization. J Immunol (Baltimore, Md : 1950) 198(3):1006\u20131014. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1601515","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"9","key":"1092_CR171","doi-asserted-by":"publisher","first-page":"e108318","DOI":"10.1371\/journal.pone.0108318","volume":"9","author":"Y Lu","year":"2014","unstructured":"Lu Y, He M, Zhang Y, Xu S, Zhang L, He Y, Chen C, Liu C et al (2014) Differential pro-inflammatory responses of astrocytes and microglia involve STAT3 activation in response to 1800 MHz radiofrequency fields. PLoS One 9(9):e108318. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0108318","journal-title":"PLoS One"},{"issue":"3","key":"1092_CR172","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","volume":"85","author":"MV Guillot-Sestier","year":"2015","unstructured":"Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J Jr, Leung BP, Rezai-Zadeh K, Town T (2015) Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85(3):534\u2013548. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2014.12.068","journal-title":"Neuron"},{"key":"1092_CR173","doi-asserted-by":"publisher","unstructured":"Doty KR, Guillot-Sestier M-V, Town T Stat3 signaling referees microglial amyloid clearance in Alzheimer’s disease. Alzheimer\u2019s Dement: J Alzheimer\u2019s Assoc 12(7):P1150. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2016.07.047","DOI":"10.1016\/j.jalz.2016.07.047"},{"key":"1092_CR174","doi-asserted-by":"publisher","unstructured":"Ulland TK, Song WM, Huang SC-C, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y et al TREM2 maintains microglial metabolic fitness in Alzheimer’s disease. Cell 170(4):649\u2013663.e613. \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.07.023","DOI":"10.1016\/j.cell.2017.07.023"},{"key":"1092_CR175","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.1038\/srep12393","volume":"5","author":"X Li","year":"2015","unstructured":"Li X, Long J, He T, Belshaw R, Scott J (2015) Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer\u2019s disease. Sci Rep 5:12393. \n                    https:\/\/doi.org\/10.1038\/srep12393","journal-title":"Sci Rep"},{"issue":"3","key":"1092_CR176","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, Zhang C, Xie T et al (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153(3):707\u2013720. \n                    https:\/\/doi.org\/10.1016\/j.cell.2013.03.030","journal-title":"Cell"},{"issue":"12","key":"1092_CR177","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","volume":"74","author":"L Zuroff","year":"2017","unstructured":"Zuroff L, Daley D, Black KL, Koronyo-Hamaoui M (2017) Clearance of cerebral A\u03b2 in Alzheimer\u2019s disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci 74(12):2167\u20132201. \n                    https:\/\/doi.org\/10.1007\/s00018-017-2463-7","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1092_CR178","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","volume":"188","author":"S Liu","year":"2011","unstructured":"Liu S, Liu Y, Hao W, Wolf L, Kiliaan AJ, Penke B, Rube CE, Walter J et al (2011) TLR2 is a primary receptor for Alzheimer\u2019s amyloid peptide to trigger neuroinflammatory activation. J Immunol 188(3):1098\u20131107. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1101121","journal-title":"J Immunol"},{"issue":"4","key":"1092_CR179","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","volume":"118","author":"WJ Streit","year":"2009","unstructured":"Streit WJ, Braak H, Xue QS, Bechmann I (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol 118(4):475\u2013485. \n                    https:\/\/doi.org\/10.1007\/s00401-009-0556-6","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1092_CR180","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.nurt.2010.05.017","volume":"7","author":"A Verkhratsky","year":"2010","unstructured":"Verkhratsky A, Olabarria M, Noristani HN, Yeh C-Y, Rodriguez JJ (2010) Astrocytes in Alzheimer\u2019s disease. Neurotherapeutics : J Am Soc Exp Neuro Ther 7(4):399\u2013412. \n                    https:\/\/doi.org\/10.1016\/j.nurt.2010.05.017","journal-title":"Neurotherapeutics : J Am Soc Exp Neuro Ther"},{"issue":"3","key":"1092_CR181","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/cdd.2008.172","volume":"16","author":"JJ Rodr\u00edguez","year":"2008","unstructured":"Rodr\u00edguez JJ, Olabarria M, Chvatal A, Verkhratsky A (2008) Astroglia in dementia and Alzheimer\u2019s disease. Cell Death Differ 16(3):378\u2013385. \n                    https:\/\/doi.org\/10.1038\/cdd.2008.172","journal-title":"Cell Death Differ"},{"issue":"6","key":"1092_CR182","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.biocel.2004.10.004","volume":"37","author":"JR Gee","year":"2005","unstructured":"Gee JR, Keller JN (2005) Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int J Biochem Cell Biol 37(6):1145\u20131150. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2004.10.004","journal-title":"Int J Biochem Cell Biol"},{"key":"1092_CR183","doi-asserted-by":"publisher","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin a. Nature. \n                    https:\/\/doi.org\/10.1038\/nature11087","DOI":"10.1038\/nature11087"},{"issue":"15","key":"1092_CR184","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc Natl Acad Sci 103(15):5644\u20135651. \n                    https:\/\/doi.org\/10.1073\/pnas.0600549103","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"1092_CR185","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1016\/j.febslet.2011.08.027","volume":"585","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Kayed R (2011) Astrocytes contain amyloid-\u03b2 annular protofibrils in Alzheimer\u2019s disease brains. FEBS Lett 585(19):3052\u20133057. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2011.08.027","journal-title":"FEBS Lett"},{"issue":"1","key":"1092_CR186","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1742-2094-8-150","volume":"8","author":"J Zhao","year":"2011","unstructured":"Zhao J, O'Connor T, Vassar R (2011) The contribution of activated astrocytes to A\u03b2 production: implications for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation 8(1):150. \n                    https:\/\/doi.org\/10.1186\/1742-2094-8-150","journal-title":"J Neuroinflammation"},{"issue":"4","key":"1092_CR187","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/1570159X12666140828214701","volume":"12","author":"I Dal Pr\u00e0","year":"2014","unstructured":"Dal Pr\u00e0 I, Chiarini A, Pacchiana R, Gardenal E, Chakravarthy B, Whitfield JF, Armato U (2014) Calcium-sensing receptors of human astrocyte-neuron teams: amyloid-\u03b2-driven mediators and therapeutic targets of Alzheimer\u2019s disease. Curr Neuropharmacol 12(4):353\u2013364. \n                    https:\/\/doi.org\/10.2174\/1570159X12666140828214701","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1092_CR188","first-page":"1","volume":"2","author":"ND Vaziri","year":"2008","unstructured":"Vaziri ND (2008) Causal link between oxidative stress, inflammation, and hypertension. Iran J Kidney Dis 2(1):1\u201310","journal-title":"Iran J Kidney Dis"},{"issue":"7","key":"1092_CR189","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2174\/1871527314666150317224645","volume":"14","author":"K Lucas","year":"2015","unstructured":"Lucas K, Morris G, Anderson G, Maes M (2015) The toll-like receptor radical cycle pathway: a new drug target in immune-related chronic fatigue. CNS Neurol Disord Drug Targets 14(7):838\u2013854","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1\u20132","key":"1092_CR190","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11010-010-0563-x","volume":"345","author":"K Jomova","year":"2010","unstructured":"Jomova K, Vondrakova D, Lawson M, Valko M (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345(1\u20132):91\u2013104. \n                    https:\/\/doi.org\/10.1007\/s11010-010-0563-x","journal-title":"Mol Cell Biochem"},{"issue":"51","key":"1092_CR191","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1073\/pnas.0508254102","volume":"102","author":"S Chang","year":"2005","unstructured":"Chang S, Ma T, Miranda RD, Balestra ME, Mahley RW, Huang Y (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci 102(51):18694\u201318699. \n                    https:\/\/doi.org\/10.1073\/pnas.0508254102","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"1092_CR192","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/archneur.64.7.954","volume":"64","author":"WR Markesbery","year":"2007","unstructured":"Markesbery WR, Lovell MA (2007) Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol 64(7):954. \n                    https:\/\/doi.org\/10.1001\/archneur.64.7.954","journal-title":"Arch Neurol"},{"issue":"1","key":"1092_CR193","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/156720507779939788","volume":"4","author":"Q Ding","year":"2007","unstructured":"Ding Q, Dimayuga E, Keller J (2007) Oxidative damage, protein synthesis, and protein degradation in Alzheimers disease. Curr Alzheimer Res 4(1):73\u201379. \n                    https:\/\/doi.org\/10.2174\/156720507779939788","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"1092_CR194","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1471-4159.2008.05603.x","volume":"107","author":"L Chen","year":"2008","unstructured":"Chen L, Na R, Gu M, Richardson A, Ran Q (2008) Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer\u2019s disease. J Neurochem 107(1):197\u2013207. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05603.x","journal-title":"J Neurochem"},{"issue":"7","key":"1092_CR195","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.neuint.2009.06.012","volume":"55","author":"R Quiroz-Baez","year":"2009","unstructured":"Quiroz-Baez R, Rojas E, Arias C (2009) Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of \u03b1-, \u03b2- and \u03b3-secretase expression. Neurochem Int 55(7):662\u2013670. \n                    https:\/\/doi.org\/10.1016\/j.neuint.2009.06.012","journal-title":"Neurochem Int"},{"key":"1092_CR196","doi-asserted-by":"publisher","unstructured":"Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo D-G, Mattson MP, Tabaton M (2007) Oxidative stress activates a positive feedback between the \u03b3- and \u03b2-secretase cleavages of the \u03b2-amyloid precursor protein. Journal of neurochemistry 0 (0):071115163316002-??? doi:\n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05072.x","DOI":"10.1111\/j.1471-4159.2007.05072.x"},{"issue":"25","key":"1092_CR197","doi-asserted-by":"publisher","first-page":"17721","DOI":"10.1074\/jbc.M800013200","volume":"283","author":"C Shen","year":"2008","unstructured":"Shen C, Chen Y, Liu H, Zhang K, Zhang T, Lin A, Jing N (2008) Hydrogen peroxide promotes A\u03b2 production through JNK-dependent activation of \u03b3-secretase. J Biol Chem 283(25):17721\u201317730. \n                    https:\/\/doi.org\/10.1074\/jbc.M800013200","journal-title":"J Biol Chem"},{"key":"1092_CR198","doi-asserted-by":"publisher","unstructured":"Sambamurti K (2004) Gene structure and organization of the human -secretase (BACE) promoter. FASEB J. \n                    https:\/\/doi.org\/10.1096\/fj.03-1378fje","DOI":"10.1096\/fj.03-1378fje"},{"key":"1092_CR199","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","volume":"1161","author":"T Matsui","year":"2007","unstructured":"Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT (2007) Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease. Brain Res 1161:116\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2007.05.050","journal-title":"Brain Res"},{"issue":"1","key":"1092_CR200","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nm0103-3","volume":"9","author":"LB Yang","year":"2003","unstructured":"Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L et al (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9(1):3\u20134. \n                    https:\/\/doi.org\/10.1038\/nm0103-3","journal-title":"Nat Med"},{"issue":"5","key":"1092_CR201","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1523\/jneurosci.4736-04.2005","volume":"25","author":"M Yao","year":"2005","unstructured":"Yao M (2005) Amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 25(5):1149\u20131158. \n                    https:\/\/doi.org\/10.1523\/jneurosci.4736-04.2005","journal-title":"J Neurosci"},{"key":"1092_CR202","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1155\/2015\/151979","volume":"2015","author":"SM Alavi Naini","year":"2015","unstructured":"Alavi Naini SM, Soussi-Yanicostas N (2015) Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative Tauopathies? Oxidative Med Cell Longev 2015:17. \n                    https:\/\/doi.org\/10.1155\/2015\/151979","journal-title":"Oxidative Med Cell Longev"},{"key":"1092_CR203","doi-asserted-by":"publisher","first-page":"352723","DOI":"10.1155\/2015\/352723","volume":"2015","author":"Z Liu","year":"2015","unstructured":"Liu Z, Li T, Li P, Wei N, Zhao Z, Liang H, Ji X, Chen W et al (2015) The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer\u2019s disease. Oxidative Med Cell Longev 2015:352723. \n                    https:\/\/doi.org\/10.1155\/2015\/352723","journal-title":"Oxidative Med Cell Longev"},{"issue":"supplement C","key":"1092_CR204","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.redox.2014.03.002","volume":"2","author":"E Giraldo","year":"2014","unstructured":"Giraldo E, Lloret A, Fuchsberger T, Vi\u00f1a J (2014) A\u03b2 and tau toxicities in Alzheimer\u2019s are linked via oxidative stress-induced p38 activation: protective role of vitamin E. Redox biology 2(supplement C):873\u2013877. \n                    https:\/\/doi.org\/10.1016\/j.redox.2014.03.002","journal-title":"Redox biology"},{"issue":"46","key":"1092_CR205","doi-asserted-by":"publisher","first-page":"14203","DOI":"10.1021\/bi001876l","volume":"39","author":"TC Gamblin","year":"2000","unstructured":"Gamblin TC, King ME, Kuret J, Berry RW, Binder LI (2000) Oxidative regulation of fatty acid-induced tau polymerization\u2020. Biochemistry 39(46):14203\u201314210. \n                    https:\/\/doi.org\/10.1021\/bi001876l","journal-title":"Biochemistry"},{"key":"1092_CR206","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0197-4580(00)83154-1","volume":"21","author":"X Zhu","year":"2000","unstructured":"Zhu X, Raina AK, Rottkamp CA, Boux H, Siedlak SL, Takeda A, Perry G, Smith MA (2000) Activation of P38 kinase links \u03c0 phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease. Neurobiol Aging 21:267. \n                    https:\/\/doi.org\/10.1016\/s0197-4580(00)83154-1","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1092_CR207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0021-9150(99)00257-9","volume":"147","author":"D Pratic\u00f2","year":"1999","unstructured":"Pratic\u00f2 D (1999) F2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 147(1):1\u201310. \n                    https:\/\/doi.org\/10.1016\/s0021-9150(99)00257-9","journal-title":"Atherosclerosis"},{"issue":"1","key":"1092_CR208","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/nbdi.1999.0273","volume":"7","author":"C Ramassamy","year":"2000","unstructured":"Ramassamy C, Averill D, Beffert U, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Schoofs A et al (2000) Oxidative insults are associated with apolipoprotein E genotype in Alzheimer\u2019s disease brain. Neurobiol Dis 7(1):23\u201337. \n                    https:\/\/doi.org\/10.1006\/nbdi.1999.0273","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1092_CR209","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0891-5849(02)01001-8","volume":"33","author":"TB Shea","year":"2002","unstructured":"Shea TB, Rogers E, Ashline D, Ortiz D, Sheu M-S (2002) Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic Biol Med 33(8):1115\u20131120. \n                    https:\/\/doi.org\/10.1016\/s0891-5849(02)01001-8","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"1092_CR210","doi-asserted-by":"publisher","first-page":"P674","DOI":"10.1016\/j.jalz.2014.05.1213","volume":"10","author":"J Dorszewska","year":"2014","unstructured":"Dorszewska J, Polrolniczak A, Prendecki M, Florczak J, Dezor M, Kowalska M, Postrach I, Kozubski W (2014) Apolipoprotein E genotype and oxidative stress in peripheral lymphocytes of patients with Alzheimer\u2019s disease. Alzheimers Dement 10(4):P674. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2014.05.1213","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1092_CR211","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, O\u2019Neil JP, Janabi M et al (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139(5):1551\u20131567. \n                    https:\/\/doi.org\/10.1093\/brain\/aww027","journal-title":"Brain"},{"issue":"2","key":"1092_CR212","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/jad-2006-9202","volume":"9","author":"PI Moreira","year":"2006","unstructured":"Moreira PI, Cardoso SM, Santos MS, Oliveira CR (2006) The key role of mitochondria in Alzheimer\u2019s disease. J Alzheimers Dis 9(2):101\u2013110. \n                    https:\/\/doi.org\/10.3233\/jad-2006-9202","journal-title":"J Alzheimers Dis"},{"key":"1092_CR213","doi-asserted-by":"publisher","unstructured":"Caspersen C (2005) Mitochondrial a : a potential focal point for neuronal metabolic dysfunction in Alzheimer\u2019s disease. FASEB J. \n                    https:\/\/doi.org\/10.1096\/fj.05-3735fje","DOI":"10.1096\/fj.05-3735fje"},{"issue":"8","key":"1092_CR214","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Li L, Perry G, Lee H-g, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta (BBA) - Mol Basis Dis 1842(8):1240\u20131247. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.015","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"2","key":"1092_CR215","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/jad-2006-9207","volume":"9","author":"X Zhu","year":"2006","unstructured":"Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA (2006) Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimers Dis 9(2):147\u2013153. \n                    https:\/\/doi.org\/10.3233\/jad-2006-9207","journal-title":"J Alzheimers Dis"},{"key":"1092_CR216","doi-asserted-by":"publisher","unstructured":"Onyango IG, Dennis J, Khan SM (2016) Mitochondrial dysfunction in Alzheimer\u2019s disease and the rationale for bioenergetics based therapies. Aging Dis (7, 2):201\u2013214. \n                    https:\/\/doi.org\/10.14336\/AD.2015.1007","DOI":"10.14336\/AD.2015.1007"},{"issue":"2","key":"1092_CR217","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/alzrt74","volume":"3","author":"A Eckert","year":"2011","unstructured":"Eckert A, Schmitt K, G\u00f6tz J (2011) Mitochondrial dysfunction\u2014the beginning of the end in Alzheimer\u2019s disease? Separate and synergistic modes of tau and amyloid-\u03b2 toxicity. Alzheimers Res Ther 3(2):15. \n                    https:\/\/doi.org\/10.1186\/alzrt74","journal-title":"Alzheimers Res Ther"},{"key":"1092_CR218","doi-asserted-by":"publisher","unstructured":"Mancuso M, Orsucci D, LoGerfo A, Calsolaro V, Siciliano G (2010) Clinical features and pathogenesis of Alzheimer\u2019s disease: Involvement of mitochondria and mitochondrial DNA. Adv Exp Med Biol Springer New York. \n                    https:\/\/doi.org\/10.1007\/978-1-4419-6448-9_4","DOI":"10.1007\/978-1-4419-6448-9_4"},{"issue":"2","key":"1092_CR219","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101\u2013112. \n                    https:\/\/doi.org\/10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"1092_CR220","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","volume":"1842","author":"JK Morris","year":"2014","unstructured":"Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM (2014) Is Alzheimer\u2019s disease a systemic disease? Biochim Biophys Acta (BBA) - Mol Basis Dis 1842(9):1340\u20131349. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2014.04.012","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"3","key":"1092_CR221","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3233\/jad-2012-111592","volume":"30","author":"K Lunnon","year":"2012","unstructured":"Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M et al (2012) Mitochondrial dysfunction and immune activation are detectable in early Alzheimer\u2019s disease blood. J Alzheimer\u2019s Dis: JAD 30(3):685\u2013710. \n                    https:\/\/doi.org\/10.3233\/jad-2012-111592","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"1","key":"1092_CR222","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12035-012-8300-y","volume":"46","author":"K Leuner","year":"2012","unstructured":"Leuner K, Schulz K, Sch\u00fctt T, Pantel J, Prvulovic D, Rhein V, Savaskan E, Czech C et al (2012) Peripheral mitochondrial dysfunction in Alzheimer\u2019s disease: focus on lymphocytes. Mol Neurobiol 46(1):194\u2013204. \n                    https:\/\/doi.org\/10.1007\/s12035-012-8300-y","journal-title":"Mol Neurobiol"},{"key":"1092_CR223","doi-asserted-by":"publisher","unstructured":"Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M (2016) Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: new pathways in neuroprogressive disorders including depression and chronic fatigue syndrome. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-016-9975-2","DOI":"10.1007\/s12035-016-9975-2"},{"issue":"2","key":"1092_CR224","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1570159x11666131120224653","volume":"12","author":"G Morris","year":"2014","unstructured":"Morris G, Maes M (2014) Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)\/chronic fatigue syndrome (CFS). Curr Neuropharmacol 12(2):168\u2013185. \n                    https:\/\/doi.org\/10.2174\/1570159x11666131120224653","journal-title":"Curr Neuropharmacol"},{"key":"1092_CR225","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11011-013-9435-x","volume":"29","author":"G Morris","year":"2014","unstructured":"Morris G, Maes M (2014) Mitochondrial dysfunctions in myalgic encephalomyelitis\/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis 29:19\u201336","journal-title":"Metab Brain Dis"},{"key":"1092_CR226","doi-asserted-by":"publisher","unstructured":"Morris G, Walder K, Carvalho AF, Tye SJ, Lucas K, Berk M, Maes M (2017) The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases. Neurosci Biobehav Rev. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2017.07.017","DOI":"10.1016\/j.neubiorev.2017.07.017"},{"issue":"8\u20139","key":"1092_CR227","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s007020050099","volume":"105","author":"GE Gibson","year":"1998","unstructured":"Gibson GE, Sheu KFR, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105(8\u20139):855\u2013870. \n                    https:\/\/doi.org\/10.1007\/s007020050099","journal-title":"J Neural Transm"},{"issue":"1","key":"1092_CR228","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1567202611310010010","volume":"10","author":"D Orsucci","year":"2012","unstructured":"Orsucci D, Mancuso M, Caldarazzo Ienco E, Simoncini C, Siciliano G, Bonuccelli U (2012) Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer\u2019s disease. Curr Neurovasc Res 10(1):76\u201380. \n                    https:\/\/doi.org\/10.2174\/1567202611310010010","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"1092_CR229","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3233\/jad-170361","volume":"60","author":"A Mise","year":"2017","unstructured":"Mise A, Yoshino Y, Yamazaki K, Ozaki Y, Sao T, Yoshida T, Mori T, Mori Y et al (2017) TOMM40 and APOE gene expression and cognitive decline in Japanese Alzheimer\u2019s disease subjects. J Alzheimer\u2019s Dis: JAD 60(3):1107\u20131117. \n                    https:\/\/doi.org\/10.3233\/jad-170361","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1092_CR230","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neulet.2016.05.050","volume":"628","author":"H Huang","year":"2016","unstructured":"Huang H, Zhao J, Xu B, Ma X, Dai Q, Li T, Xue F, Chen B (2016) The TOMM40 gene rs2075650 polymorphism contributes to Alzheimer\u2019s disease in Caucasian, and Asian populations. Neurosci Lett 628:142\u2013146. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2016.05.050","journal-title":"Neurosci Lett"},{"issue":"1","key":"1092_CR231","doi-asserted-by":"publisher","first-page":"12","DOI":"10.13188\/2376-922X.1000003","volume":"1","author":"WK Gottschalk","year":"2014","unstructured":"Gottschalk WK, Lutz MW, He YT, Saunders AM, Burns DK, Roses AD, Chiba-Falek O (2014) The broad impact of TOM40 on neurodegenerative diseases in aging. J Parkinson\u2019s Dis Alzheimer\u2019s Dis 1(1):12. \n                    https:\/\/doi.org\/10.13188\/2376-922X.1000003","journal-title":"J Parkinson\u2019s Dis Alzheimer\u2019s Dis"},{"issue":"1","key":"1092_CR232","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, Tyagi N (2016) Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies. Mol Neurobiol 53(1):648\u2013661. \n                    https:\/\/doi.org\/10.1007\/s12035-014-9053-6","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1092_CR233","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis 57(4):1105\u20131121. \n                    https:\/\/doi.org\/10.3233\/JAD-161088","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1092_CR234","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/jad-2010-100129","volume":"22","author":"J Valla","year":"2010","unstructured":"Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ et al (2010) Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer\u2019s susceptibility gene. J Alzheimer\u2019s Dis: JAD 22(1):307\u2013313. \n                    https:\/\/doi.org\/10.3233\/jad-2010-100129","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"9","key":"1092_CR235","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.neurobiolaging.2014.03.006","volume":"35","author":"DS Knopman","year":"2014","unstructured":"Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K et al (2014) 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiol Aging 35(9):2096\u20132106. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.006","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1092_CR236","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JAD-160702","volume":"57","author":"L Guo","year":"2017","unstructured":"Guo L, Tian J, Du H (2017) Mitochondrial dysfunction and synaptic transmission failure in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 57(4):1071\u20131086. \n                    https:\/\/doi.org\/10.3233\/JAD-160702","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"3","key":"1092_CR237","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","volume":"6","author":"S Tangvarasittichai","year":"2015","unstructured":"Tangvarasittichai S (2015) Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 6(3):456\u2013480. \n                    https:\/\/doi.org\/10.4239\/wjd.v6.i3.456","journal-title":"World J Diabetes"},{"issue":"12","key":"1092_CR238","doi-asserted-by":"publisher","first-page":"e0144116","DOI":"10.1371\/journal.pone.0144116","volume":"10","author":"CA Castellano","year":"2015","unstructured":"Castellano CA, Baillargeon JP, Nugent S, Tremblay S, Fortier M, Imbeault H, Duval J, Cunnane SC (2015) Regional brain glucose hypometabolism in young women with polycystic ovary syndrome: possible link to mild insulin resistance. PLoS One 10(12):e0144116. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0144116","journal-title":"PLoS One"},{"issue":"1","key":"1092_CR239","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/archneurol.2010.225","volume":"68","author":"LD Baker","year":"2011","unstructured":"Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68(1):51\u201357. \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.225","journal-title":"Arch Neurol"},{"key":"1092_CR240","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fnsyn.2010.00139","volume":"2","author":"M Vos","year":"2010","unstructured":"Vos M, Lauwers E, Verstreken P (2010) Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synaptic Neurosci 2:139. \n                    https:\/\/doi.org\/10.3389\/fnsyn.2010.00139","journal-title":"Front Synaptic Neurosci"},{"issue":"12","key":"1092_CR241","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1089\/ars.2011.4277","volume":"16","author":"H Du","year":"2012","unstructured":"Du H, Guo L, Yan SS (2012) Synaptic mitochondrial pathology in Alzheimer\u2019s disease. Antioxid Redox Signal 16(12):1467\u20131475. \n                    https:\/\/doi.org\/10.1089\/ars.2011.4277","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"1092_CR242","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3233\/JAD-160726","volume":"57","author":"Q Cai","year":"2017","unstructured":"Cai Q, Tammineni P (2017) Mitochondrial aspects of synaptic dysfunction in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 57(4):1087\u20131103. \n                    https:\/\/doi.org\/10.3233\/JAD-160726","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1092_CR243","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1570159X11666131120224653","volume":"12","author":"G Morris","year":"2014","unstructured":"Morris G, Maes M (2014) Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)\/chronic fatigue syndrome (CFS). Curr Neuropharmacol 12:168\u2013185","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"1092_CR244","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1007\/s12035-015-9392-y","volume":"53","author":"G Morris","year":"2016","unstructured":"Morris G, Walder K, Puri BK, Berk M, Maes M (2016) The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling: new drug targets in neuroimmune disorders. Mol Neurobiol 53(7):4638\u20134658. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9392-y","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1092_CR245","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3233\/jad-2011-101785","volume":"24","author":"M Arai","year":"2011","unstructured":"Arai M, Saito M, Takatsu H, Fukui K, Urano S (2011) Dysfunction of the fusion of pre-synaptic plasma membranes and synaptic vesicles caused by oxidative stress, and its prevention by vitamin E. J Alzheimer\u2019s Dis: JAD 24(4):759\u2013766. \n                    https:\/\/doi.org\/10.3233\/jad-2011-101785","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"4","key":"1092_CR246","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3177\/jnsv.52.248","volume":"52","author":"NO Omoi","year":"2006","unstructured":"Omoi NO, Arai M, Saito M, Takatsu H, Shibata A, Fukuzawa K, Sato K, Abe K et al (2006) Influence of oxidative stress on fusion of pre-synaptic plasma membranes of the rat brain with phosphatidyl choline liposomes, and protective effect of vitamin E. J Nutr Sci Vitaminol 52(4):248\u2013255","journal-title":"J Nutr Sci Vitaminol"},{"key":"1092_CR247","doi-asserted-by":"publisher","unstructured":"Wang X, Michaelis E (2010) Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2(12). \n                    https:\/\/doi.org\/10.3389\/fnagi.2010.00012","DOI":"10.3389\/fnagi.2010.00012"},{"issue":"1","key":"1092_CR248","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer\u2019s disease: targeting the cholinergic system. Curr Neuropharmacol 14(1):101\u2013115. \n                    https:\/\/doi.org\/10.2174\/1570159X13666150716165726","journal-title":"Curr Neuropharmacol"},{"key":"1092_CR249","doi-asserted-by":"publisher","unstructured":"A. G S, Jane R (2011) Impact of oxidative - nitrosative stress on cholinergic presynaptic function. Alzheimer\u2019s Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets. InTech. doi:\n                    https:\/\/doi.org\/10.5772\/20198","DOI":"10.5772\/20198"},{"key":"1092_CR250","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cbpc.2015.04.003","volume":"172-173","author":"G Rodr\u00edguez-Fuentes","year":"2015","unstructured":"Rodr\u00edguez-Fuentes G, Rubio-Escalante FJ, Nore\u00f1a-Barroso E, Escalante-Herrera KS, Schlenk D (2015) Impacts of oxidative stress on acetylcholinesterase transcription, and activity in embryos of zebrafish (Danio rerio) following chlorpyrifos exposure. Comp Biochem Physiol Part C: Toxicol Pharmacol 172-173:19\u201325. \n                    https:\/\/doi.org\/10.1016\/j.cbpc.2015.04.003","journal-title":"Comp Biochem Physiol Part C: Toxicol Pharmacol"},{"issue":"3","key":"1092_CR251","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2478\/v10102-011-0023-9","volume":"4","author":"A Santi","year":"2011","unstructured":"Santi A, Menezes C, Duarte MMF, Leitemperger J, L\u00f3pes T, Loro VL (2011) Oxidative stress biomarkers and acetylcholinesterase activity in human erythrocytes exposed to clomazone (in vitro). Interdiscip Toxicol 4(3):149\u2013153. \n                    https:\/\/doi.org\/10.2478\/v10102-011-0023-9","journal-title":"Interdiscip Toxicol"},{"issue":"5","key":"1092_CR252","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3969\/j.issn.1673-5374.2012.05.009","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J (2012) Oxidative stress in neurodegenerative diseases. Neural Regen Res 7(5):376\u2013385. \n                    https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.05.009","journal-title":"Neural Regen Res"},{"issue":"7","key":"1092_CR253","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s11064-014-1313-3","volume":"39","author":"Q Fu","year":"2014","unstructured":"Fu Q, Gao N, Yu J, Ma G, Du Y, Wang F, Su Q, Che F (2014) Diazoxide pretreatment prevents Abeta1-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression. Neurochem Res 39(7):1313\u20131321. \n                    https:\/\/doi.org\/10.1007\/s11064-014-1313-3","journal-title":"Neurochem Res"},{"issue":"7","key":"1092_CR254","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","volume":"37","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li P, Feng J, Wu M (2016) Dysfunction of NMDA receptors in Alzheimer's disease. Neurol Sci: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 37(7):1039\u20131047. \n                    https:\/\/doi.org\/10.1007\/s10072-016-2546-5","journal-title":"Neurol Sci: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"3","key":"1092_CR255","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuroscience.2005.10.014","volume":"137","author":"P Steullet","year":"2006","unstructured":"Steullet P, Neijt HC, Cuenod M, Do KQ (2006) Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia. Neuroscience 137(3):807\u2013819. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2005.10.014","journal-title":"Neuroscience"},{"issue":"1","key":"1092_CR256","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12916-015-0310-y","volume":"13","author":"G Morris","year":"2015","unstructured":"Morris G, Berk M (2015) The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med 13(1):68","journal-title":"BMC Med"},{"issue":"1","key":"1092_CR257","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proc Natl Acad Sci U S A 101(1):284\u2013289. \n                    https:\/\/doi.org\/10.1073\/pnas.2635903100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1092_CR258","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.nicl.2017.09.016","volume":"17","author":"L Iaccarino","year":"2018","unstructured":"Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M et al (2018) Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer\u2019s disease. NeuroImage : Clinical 17:452\u2013464. \n                    https:\/\/doi.org\/10.1016\/j.nicl.2017.09.016","journal-title":"NeuroImage : Clinical"},{"issue":"supplement C","key":"1092_CR259","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neurobiolaging.2017.08.008","volume":"59","author":"JM Kang","year":"2017","unstructured":"Kang JM, Lee S-Y, Seo S, Jeong HJ, Woo S-H, Lee H, Lee Y-B, Yeon BK et al (2017) Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer\u2019s disease. Neurobiology of aging 59(supplement C):210\u2013219. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.08.008","journal-title":"Neurobiology of aging"},{"key":"1092_CR260","doi-asserted-by":"publisher","unstructured":"Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M et al (2017) Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer\u2019s disease dementia. Mol Psychiatry. \n                    https:\/\/doi.org\/10.1038\/mp.2017.108\n                    \n                   \n                    https:\/\/www.nature.com\/articles\/mp2017108#supplementary-information","DOI":"10.1038\/mp.2017.108"},{"issue":"12","key":"1092_CR261","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/acn3.339","volume":"3","author":"GN Bischof","year":"2016","unstructured":"Bischof GN, Jessen F, Fliessbach K, Dronse J, Hammes J, Neumaier B, Onur O, Fink GR et al (2016) Impact of tau and amyloid burden on glucose metabolism in Alzheimer\u2019s disease. Ann Clin Transl Neurol 3(12):934\u2013939. \n                    https:\/\/doi.org\/10.1002\/acn3.339","journal-title":"Ann Clin Transl Neurol"},{"key":"1092_CR262","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4061\/2011\/985085","volume":"2011","author":"K Kanninen","year":"2011","unstructured":"Kanninen K, White AR, Koistinaho J, Malm T (2011) Targeting glycogen synthase kinase-3\u03b2 for therapeutic benefit against oxidative stress in Alzheimer\u2019s disease: involvement of the Nrf2-ARE pathway. International Journal of Alzheimer’s Disease 2011:9. \n                    https:\/\/doi.org\/10.4061\/2011\/985085","journal-title":"International Journal of Alzheimer’s Disease"},{"issue":"7","key":"1092_CR263","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2174\/156720512802455386","volume":"9","author":"Z Cai","year":"2012","unstructured":"Cai Z, Zhao Y, Zhao B (2012) Roles of glycogen synthase kinase 3 in Alzheimer\u2019s disease. Curr Alzheimer Res 9(7):864\u2013879","journal-title":"Curr Alzheimer Res"},{"issue":"Pt a","key":"1092_CR264","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.01.014","volume":"74","author":"G Morris","year":"2017","unstructured":"Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M (2017) A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav rev 74(Pt a):1\u201320. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2017.01.014","journal-title":"Neurosci Biobehav rev"},{"key":"1092_CR265","doi-asserted-by":"publisher","unstructured":"Bradley C, Peineau S, Taghibiglou C, Nicolas C, Whitcomb D, Bortolotto Z, Kaang B-K, Cho K et al (2012) A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci 5(13). \n                    https:\/\/doi.org\/10.3389\/fnmol.2012.00013","DOI":"10.3389\/fnmol.2012.00013"},{"issue":"6","key":"1092_CR266","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 104(6):1433\u20131439. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05194.x","journal-title":"J Neurochem"},{"issue":"7","key":"1092_CR267","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci 101(7):2173\u20132178. \n                    https:\/\/doi.org\/10.1073\/pnas.0308512100","journal-title":"Proc Natl Acad Sci"},{"key":"1092_CR268","doi-asserted-by":"publisher","unstructured":"Leroy K, Yilmaz Z, Brion JP (2007) Increased level of active GSK-3? In Alzheimer\u2019s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33(1). \n                    https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00795.x","DOI":"10.1111\/j.1365-2990.2006.00795.x"},{"issue":"1","key":"1092_CR269","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","volume":"56","author":"J-J Pei","year":"1997","unstructured":"Pei J-J, Tanaka T, Tung Y-C, Braak EVA, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56(1):70\u201378. \n                    https:\/\/doi.org\/10.1097\/00005072-199701000-00007","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"1092_CR270","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","volume":"58","author":"J-J Pei","year":"1999","unstructured":"Pei J-J, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (1999) Distribution of active glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58(9):1010\u20131019. \n                    https:\/\/doi.org\/10.1097\/00005072-199909000-00011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"1092_CR271","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s004010050513","volume":"92","author":"H Yamaguchi","year":"1996","unstructured":"Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K (1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I\/glycogen synthase kinase-3\u03b2 and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol 92(3):232\u2013241. \n                    https:\/\/doi.org\/10.1007\/s004010050513","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1092_CR272","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2004.10.031","volume":"373","author":"A Hye","year":"2004","unstructured":"Hye A, Kerr F, Archer N, Foy C, Poppe M, Brown R, Hamilton G, Powell J et al (2004) Glycogen synthase kinase-3 is increased in white cells early in Alzheimer\u2019s disease. Neurosci Lett 373(1):1\u20134. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2004.10.031","journal-title":"Neurosci Lett"},{"issue":"4","key":"1092_CR273","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000091044","volume":"21","author":"I Mateo","year":"2006","unstructured":"Mateo I, Infante J, Llorca J, Rodr\u00edguez E, Berciano J, Combarros O (2006) Association between glycogen synthase kinase-3\u03b2 genetic polymorphism and late-onset Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 21(4):228\u2013232. \n                    https:\/\/doi.org\/10.1159\/000091044","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"12","key":"1092_CR274","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1111\/j.1460-9568.2006.05243.x","volume":"24","author":"AA Asuni","year":"2006","unstructured":"Asuni AA, Hooper C, Reynolds CH, Lovestone S, Anderton BH, Killick R (2006) GSK3\u03b1 exhibits \u03b2-catenin and tau directed kinase activities that are modulated by Wnt. Eur J Neurosci 24(12):3387\u20133392. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05243.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"1092_CR275","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1471-4159.2004.02155.x","volume":"88","author":"JH Cho","year":"2004","unstructured":"Cho JH, Johnson GV (2004) Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J Neurochem 88(2):349\u2013358","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"1092_CR276","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0304-3940(01)02583-6","volume":"321","author":"X Sun","year":"2002","unstructured":"Sun X, Sato S, Murayama O, Murayama M, Park JM, Yamaguchi H, Takashima A (2002) Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100. Neurosci Lett 321(1\u20132):61\u201364. \n                    https:\/\/doi.org\/10.1016\/s0304-3940(01)02583-6","journal-title":"Neurosci Lett"},{"issue":"6938","key":"1092_CR277","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ, Wilson CA, Lee VMY, Klein PS (2003) GSK-3\u03b1 regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides. Nature 423(6938):435\u2013439. \n                    https:\/\/doi.org\/10.1038\/nature01640","journal-title":"Nature"},{"issue":"4","key":"1092_CR278","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.neurobiolaging.2012.09.012","volume":"34","author":"TL Sudduth","year":"2013","unstructured":"Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM (2013) Neuroinflammatory phenotype in early Alzheimer\u2019s disease. Neurobiol Aging 34(4):1051\u20131059. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.09.012","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1092_CR279","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1750-3639.2002.tb00449.x","volume":"12","author":"T Revesz","year":"2006","unstructured":"Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, Frangione B (2006) Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 12(3):343\u2013357. \n                    https:\/\/doi.org\/10.1111\/j.1750-3639.2002.tb00449.x","journal-title":"Brain Pathol"},{"issue":"Suppl 1","key":"1092_CR280","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1471-4159.2011.07519.x","volume":"120","author":"H Zhang","year":"2012","unstructured":"Zhang H, Ma Q, Zhang YW, Xu H (2012) Proteolytic processing of Alzheimer\u2019s beta-amyloid precursor protein. J Neurochem 120(Suppl 1):9\u201321. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07519.x","journal-title":"J Neurochem"},{"issue":"7","key":"1092_CR281","first-page":"904","volume":"36","author":"YJ He","year":"2016","unstructured":"He YJ, Wei PR, Wu QY, Zhang XY, Zhang XM, Liu XJ, Wang F (2016) ApoE4 increases glycogen synthase kinase 3beta expression and tau phosphorylation in U87 cells. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 36(7):904\u2013908","journal-title":"Nan fang yi ke da xue xue bao = Journal of Southern Medical University"},{"issue":"5","key":"1092_CR282","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1046\/j.1471-4159.2003.02088.x","volume":"87","author":"A Cedazo-Minguez","year":"2003","unstructured":"Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, Akterin S, Pei JJ, Winblad B, Cowburn RF (2003) Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta. J Neurochem 87(5):1152\u20131164","journal-title":"J Neurochem"},{"issue":"4","key":"1092_CR283","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000348599","volume":"59","author":"M Markaki","year":"2013","unstructured":"Markaki M, Tavernarakis N (2013) Metabolic control by target of rapamycin and autophagy during ageing\u2014a mini-review. Gerontology 59(4):340\u2013348","journal-title":"Gerontology"},{"key":"1092_CR284","doi-asserted-by":"publisher","unstructured":"Yu L, Chen Y, Tooze SA (2017) Autophagy pathway: cellular and molecular mechanisms. Autophagy:1\u20139. \n                    https:\/\/doi.org\/10.1080\/15548627.2017.1378838","DOI":"10.1080\/15548627.2017.1378838"},{"issue":"2","key":"1092_CR285","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1582-4934.2008.00276.x","volume":"12","author":"S Oddo","year":"2008","unstructured":"Oddo S (2008) The ubiquitin-proteasome system in Alzheimer\u2019s disease. J Cell Mol Med 12(2):363\u2013373. \n                    https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00276.x","journal-title":"J Cell Mol Med"},{"key":"1092_CR286","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fnagi.2017.00320","volume":"9","author":"M Guglielmotto","year":"2017","unstructured":"Guglielmotto M, Monteleone D, Vasciaveo V, Repetto IE, Manassero G, Tabaton M, Tamagno E (2017) The decrease of Uch-L1 activity is a common mechanism responsible for A\u03b2 42 accumulation in Alzheimer\u2019s and vascular disease. Front Aging Neurosci 9:320. \n                    https:\/\/doi.org\/10.3389\/fnagi.2017.00320","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1092_CR287","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/alzrt217","volume":"5","author":"ME Orr","year":"2013","unstructured":"Orr ME, Oddo S (2013) Autophagic\/lysosomal dysfunction in Alzheimer\u2019s disease. Alzheimers Res Ther 5(5):53. \n                    https:\/\/doi.org\/10.1186\/alzrt217","journal-title":"Alzheimers Res Ther"},{"issue":"32","key":"1092_CR288","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.1009485107","volume":"107","author":"MM Lipinski","year":"2010","unstructured":"Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C et al (2010) Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 107(32):14164\u201314169. \n                    https:\/\/doi.org\/10.1073\/pnas.1009485107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1092_CR289","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3233\/jad-2010-101080","volume":"22","author":"SD Ginsberg","year":"2010","unstructured":"Ginsberg SD, Mufson EJ, Counts SE, Wuu J, Alldred MJ, Nixon RA, Che S (2010) Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 22(2):631\u2013639. \n                    https:\/\/doi.org\/10.3233\/jad-2010-101080","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"1","key":"1092_CR290","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2004.12.004","volume":"27","author":"M Mishto","year":"2006","unstructured":"Mishto M, Bellavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B, Spazzafumo L, Chiappelli M et al (2006) Immunoproteasome and LMP2 polymorphism in aged and Alzheimer\u2019s disease brains. Neurobiol Aging 27(1):54\u201366. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.12.004","journal-title":"Neurobiol Aging"},{"issue":"13","key":"1092_CR291","doi-asserted-by":"publisher","first-page":"13256","DOI":"10.1074\/jbc.M314124200","volume":"279","author":"J Choi","year":"2004","unstructured":"Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson\u2019s and Alzheimer\u2019s diseases. J Biol Chem 279(13):13256\u201313264. \n                    https:\/\/doi.org\/10.1074\/jbc.M314124200","journal-title":"J Biol Chem"},{"issue":"7","key":"1092_CR292","doi-asserted-by":"publisher","first-page":"586","DOI":"10.18632\/aging.100070","volume":"1","author":"SL Hands","year":"2009","unstructured":"Hands SL, Proud CG, Wyttenbach A (2009) mTOR\u2019s role in ageing: protein synthesis or autophagy? Aging 1(7):586\u2013597","journal-title":"Aging"},{"issue":"Pt 20","key":"1092_CR293","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122(Pt 20):3589\u20133594. \n                    https:\/\/doi.org\/10.1242\/jcs.051011","journal-title":"J Cell Sci"},{"issue":"2","key":"1092_CR294","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini David M (2012) mTOR signaling in growth control and disease. Cell 149(2):274\u2013293. \n                    https:\/\/doi.org\/10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"issue":"8","key":"1092_CR295","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/07853890.2014.941921","volume":"46","author":"K Maiese","year":"2014","unstructured":"Maiese K (2014) Taking aim at Alzheimer\u2019s disease through the mammalian target of rapamycin. Ann Med 46(8):587\u2013596. \n                    https:\/\/doi.org\/10.3109\/07853890.2014.941921","journal-title":"Ann Med"},{"issue":"2","key":"1092_CR296","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/jad-131124","volume":"38","author":"YX Sun","year":"2014","unstructured":"Sun YX, Ji X, Mao X, Xie L, Jia J, Galvan V, Greenberg DA, Jin K (2014) Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 38(2):437\u2013444. \n                    https:\/\/doi.org\/10.3233\/jad-131124","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"7","key":"1092_CR297","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.exger.2013.02.025","volume":"48","author":"C O\u2019Neill","year":"2013","unstructured":"O\u2019Neill C (2013) PI3-kinase\/Akt\/mTOR signaling: impaired on\/off switches in aging, cognitive decline and Alzheimer\u2019s disease. Exp Gerontol 48(7):647\u2013653. \n                    https:\/\/doi.org\/10.1016\/j.exger.2013.02.025","journal-title":"Exp Gerontol"},{"key":"1092_CR298","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbr.2014.02.005","volume":"264","author":"F Yang","year":"2014","unstructured":"Yang F, Chu X, Yin M, Liu X, Yuan H, Niu Y, Fu L (2014) mTOR and autophagy in normal brain aging and caloric restriction ameliorating age-related cognition deficits. Behav Brain Res 264:82\u201390. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2014.02.005","journal-title":"Behav Brain Res"},{"key":"1092_CR299","doi-asserted-by":"publisher","first-page":"7082696","DOI":"10.1155\/2017\/7082696","volume":"2017","author":"L Ryskalin","year":"2017","unstructured":"Ryskalin L, Lazzeri G, Flaibani M, Biagioni F, Gambardella S, Frati A, Fornai F (2017) mTOR-dependent cell proliferation in the brain. Biomed Res Int 2017:7082696. \n                    https:\/\/doi.org\/10.1155\/2017\/7082696","journal-title":"Biomed Res Int"},{"key":"1092_CR300","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2051-5960-1-3","volume":"1","author":"SC Yates","year":"2013","unstructured":"Yates SC, Zafar A, Hubbard P, Nagy S, Durant S, Bicknell R, Wilcock G, Christie S et al (2013) Dysfunction of the mTOR pathway is a risk factor for Alzheimer\u2019s disease. Acta Neuropathol Commun 1:3. \n                    https:\/\/doi.org\/10.1186\/2051-5960-1-3","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"1092_CR301","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jnc.12098","volume":"124","author":"GK Gouras","year":"2012","unstructured":"Gouras GK (2012) mTOR: at the crossroads of aging, chaperones, and Alzheimer\u2019s disease. J Neurochem 124(6):747\u2013748. \n                    https:\/\/doi.org\/10.1111\/jnc.12098","journal-title":"J Neurochem"},{"issue":"17","key":"1092_CR302","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.m110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Majumder S, Richardson A, Strong R, Oddo S (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and tau. J Biol Chem 285(17):13107\u201313120. \n                    https:\/\/doi.org\/10.1074\/jbc.m110.100420","journal-title":"J Biol Chem"},{"issue":"22","key":"1092_CR303","doi-asserted-by":"publisher","first-page":"15556","DOI":"10.1074\/jbc.m112.435123","volume":"288","author":"Z Tang","year":"2013","unstructured":"Tang Z, Bereczki E, Zhang H, Wang S, Li C, Ji X, Branca RM, Lehti\u00f6 J et al (2013) Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis. J Biol Chem 288(22):15556\u201315570. \n                    https:\/\/doi.org\/10.1074\/jbc.m112.435123","journal-title":"J Biol Chem"},{"issue":"4","key":"1092_CR304","doi-asserted-by":"publisher","first-page":"P315","DOI":"10.1016\/j.jalz.2013.04.139","volume":"9","author":"S Oddo","year":"2013","unstructured":"Oddo S (2013) The relationship among mTOR, beta-amyloid and tau: therapeutic implications for Alzheimer\u2019s disease. Alzheimers Dement 9(4):P315. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2013.04.139","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1092_CR305","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1016\/j.jalz.2010.05.519","volume":"6","author":"S Oddo","year":"2010","unstructured":"Oddo S (2010) Molecular interplay between mTOR, A\u03b2 and tau: effects on cognitive impairments. Alzheimers Dement 6(4):S167. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2010.05.519","journal-title":"Alzheimers Dement"},{"issue":"7170","key":"1092_CR306","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nature06322","volume":"450","author":"JT Cunningham","year":"2007","unstructured":"Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P (2007) mTOR controls mitochondrial oxidative function through a YY1\u2013PGC-1\u03b1 transcriptional complex. Nature 450(7170):736\u2013740. \n                    https:\/\/doi.org\/10.1038\/nature06322","journal-title":"Nature"},{"issue":"16","key":"1092_CR307","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1182\/blood-2010-09-310888","volume":"117","author":"T Weichhart","year":"2011","unstructured":"Weichhart T, Haidinger M, Katholnig K, Kopecky C, Poglitsch M, Lassnig C, Rosner M, Zlabinger GJ et al (2011) Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood 117(16):4273\u20134283. \n                    https:\/\/doi.org\/10.1182\/blood-2010-09-310888","journal-title":"Blood"},{"issue":"4","key":"1092_CR308","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-079x.2007.00539.x","volume":"44","author":"SR Kimball","year":"2008","unstructured":"Kimball SR, Abbas A, Jefferson LS (2008) Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras. J Pineal Res 44(4):379\u2013386. \n                    https:\/\/doi.org\/10.1111\/j.1600-079x.2007.00539.x","journal-title":"J Pineal Res"},{"key":"1092_CR309","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.redox.2013.12.008","volume":"2","author":"T Jung","year":"2014","unstructured":"Jung T, H\u00f6hn A, Grune T (2014) The proteasome and the degradation of oxidized proteins: part II\u2014protein oxidation and proteasomal degradation. Redox Biol 2:99\u2013104. \n                    https:\/\/doi.org\/10.1016\/j.redox.2013.12.008","journal-title":"Redox Biol"},{"key":"1092_CR310","doi-asserted-by":"publisher","unstructured":"Aiken CT, Kaake RM, Wang X, Huang L (2011) Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteomics. \n                    https:\/\/doi.org\/10.1074\/mcp.r110.006924","DOI":"10.1074\/mcp.r110.006924"},{"issue":"3\u20134","key":"1092_CR311","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0300-9084(01)01250-0","volume":"83","author":"KJA Davies","year":"2001","unstructured":"Davies KJA (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83(3\u20134):301\u2013310. \n                    https:\/\/doi.org\/10.1016\/s0300-9084(01)01250-0","journal-title":"Biochimie"},{"issue":"32","key":"1092_CR312","doi-asserted-by":"publisher","first-page":"30057","DOI":"10.1074\/jbc.m100142200","volume":"276","author":"A-L Bulteau","year":"2001","unstructured":"Bulteau A-L, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI (2001) Oxidative modification and inactivation of the proteasome during coronary occlusion\/reperfusion. J Biol Chem 276(32):30057\u201330063. \n                    https:\/\/doi.org\/10.1074\/jbc.m100142200","journal-title":"J Biol Chem"},{"issue":"39","key":"1092_CR313","doi-asserted-by":"publisher","first-page":"16310","DOI":"10.1074\/jbc.M117.803619","volume":"292","author":"X Wang","year":"2017","unstructured":"Wang X, Chemmama IE, Yu C, Huszagh A, Xu Y, Viner R, Block SA, Cimermancic P et al (2017) The proteasome-interacting Ecm29 protein disassembles the 26S proteasome in response to oxidative stress. J Biol Chem 292(39):16310\u201316320. \n                    https:\/\/doi.org\/10.1074\/jbc.M117.803619","journal-title":"J Biol Chem"},{"key":"1092_CR314","doi-asserted-by":"publisher","unstructured":"Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R et al (2008) Dopamine-modified \u03b1-synuclein blocks chaperone-mediated autophagy. J Clin Investig. \n                    https:\/\/doi.org\/10.1172\/jci32806","DOI":"10.1172\/jci32806"},{"issue":"6","key":"1092_CR315","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4161\/auto.28477","volume":"10","author":"L Zhang","year":"2014","unstructured":"Zhang L, Sun Y, Fei M, Tan C, Wu J, Zheng J, Tang J, Sun W et al (2014) Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization. Autophagy 10(6):1015\u20131035. \n                    https:\/\/doi.org\/10.4161\/auto.28477","journal-title":"Autophagy"},{"issue":"2","key":"1092_CR316","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1042\/0264-6021:3600355","volume":"360","author":"F-Y Wan","year":"2001","unstructured":"Wan F-Y, Wang Y-N, Zhang G-J (2001) The influence of oxidation of membrane thiol groups on lysosomal proton permeability. Biochem J 360(2):355. \n                    https:\/\/doi.org\/10.1042\/0264-6021:3600355","journal-title":"Biochem J"},{"issue":"3","key":"1092_CR317","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/ars.2008.2263","volume":"11","author":"VN Pivtoraiko","year":"2009","unstructured":"Pivtoraiko VN, Stone SL, Roth KA, Shacka JJ (2009) Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death. Antioxid Redox Signal 11(3):481\u2013496. \n                    https:\/\/doi.org\/10.1089\/ars.2008.2263","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"1092_CR318","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/nbdi.2000.0364","volume":"8","author":"K Ditaranto","year":"2001","unstructured":"Ditaranto K, Tekirian TL, Yang AJ (2001) Lysosomal membrane damage in soluble A\u03b2-mediated cell death in Alzheimer\u2019s disease. Neurobiol Dis 8(1):19\u201331. \n                    https:\/\/doi.org\/10.1006\/nbdi.2000.0364","journal-title":"Neurobiol Dis"},{"issue":"11","key":"1092_CR319","doi-asserted-by":"publisher","first-page":"e81093","DOI":"10.1371\/journal.pone.0081093","volume":"8","author":"J Acosta-Cabronero","year":"2013","unstructured":"Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ (2013) In vivo quantitative susceptibility mapping (QSM) in Alzheimer\u2019s disease. PLoS One 8(11):e81093. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0081093","journal-title":"PLoS One"},{"issue":"2","key":"1092_CR320","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiol.2532082324","volume":"253","author":"WZ Zhu","year":"2009","unstructured":"Zhu WZ, Zhong WD, Wang W, Zhan CJ, Wang CY, Qi JP, Wang JZ, Lei T (2009) Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 253(2):497\u2013504. \n                    https:\/\/doi.org\/10.1148\/radiol.2532082324","journal-title":"Radiology"},{"issue":"4","key":"1092_CR321","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s11596-011-0493-1","volume":"31","author":"Y Qin","year":"2011","unstructured":"Qin Y, Zhu W, Zhan C, Zhao L, Wang J, Tian Q, Wang W (2011) Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2\u2019 mapping. J Huazhong Univ Sci Technol Med Sci= Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 31(4):578\u2013585. \n                    https:\/\/doi.org\/10.1007\/s11596-011-0493-1","journal-title":"J Huazhong Univ Sci Technol Med Sci= Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban"},{"issue":"1","key":"1092_CR322","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/jad-2010-1239","volume":"19","author":"MA Smith","year":"2010","unstructured":"Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW Jr, Cohen ML, Wang X, Siedlak SL et al (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimer\u2019s Dis: JAD 19(1):363\u2013372. \n                    https:\/\/doi.org\/10.3233\/jad-2010-1239","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"9","key":"1092_CR323","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","volume":"1823","author":"T Ganz","year":"2012","unstructured":"Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434\u20131443. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2012.01.014","journal-title":"Biochim Biophys Acta"},{"key":"1092_CR324","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/asheducation-2013.1.1","volume":"2013","author":"C Camaschella","year":"2013","unstructured":"Camaschella C (2013) Iron and hepcidin: a story of recycling and balance. Hematol Am Soc Hematol Educ Program 2013:1\u20138. \n                    https:\/\/doi.org\/10.1182\/asheducation-2013.1.1","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"44","key":"1092_CR325","doi-asserted-by":"publisher","first-page":"37472","DOI":"10.1074\/jbc.M112.358911","volume":"287","author":"G Millonig","year":"2012","unstructured":"Millonig G, Ganzleben I, Peccerella T, Casanovas G, Brodziak-Jarosz L, Breitkopf-Heinlein K, Dick TP, Seitz HK et al (2012) Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). J Biol Chem 287(44):37472\u201337482. \n                    https:\/\/doi.org\/10.1074\/jbc.M112.358911","journal-title":"J Biol Chem"},{"issue":"9","key":"1092_CR326","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/jci20945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113(9):1271\u20131276. \n                    https:\/\/doi.org\/10.1172\/jci20945","journal-title":"J Clin Invest"},{"issue":"1","key":"1092_CR327","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/j.gastro.2006.10.018","volume":"132","author":"A Pietrangelo","year":"2007","unstructured":"Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, Ernst M, Klein C et al (2007) STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132(1):294\u2013300. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2006.10.018","journal-title":"Gastroenterology"},{"issue":"1","key":"1092_CR328","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1182\/blood-2006-07-033969","volume":"109","author":"MV Verga Falzacappa","year":"2007","unstructured":"Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109(1):353\u2013358. \n                    https:\/\/doi.org\/10.1182\/blood-2006-07-033969","journal-title":"Blood"},{"issue":"9","key":"1092_CR329","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","volume":"108","author":"DM Wrighting","year":"2006","unstructured":"Wrighting DM, Andrews NC (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108(9):3204\u20133209. \n                    https:\/\/doi.org\/10.1182\/blood-2006-06-027631","journal-title":"Blood"},{"issue":"4","key":"1092_CR330","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jnc.12244","volume":"126","author":"P Urrutia","year":"2013","unstructured":"Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, Gonzalez-Billault C, Nunez MT (2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 126(4):541\u2013549. \n                    https:\/\/doi.org\/10.1111\/jnc.12244","journal-title":"J Neurochem"},{"key":"1092_CR331","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fneng.2013.00007","volume":"6","author":"AD Wong","year":"2013","unstructured":"Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE, Searson PC (2013) The blood-brain barrier: an engineering perspective. Frontiers Neuroengineering 6:7. \n                    https:\/\/doi.org\/10.3389\/fneng.2013.00007","journal-title":"Frontiers Neuroengineering"},{"issue":"5","key":"1092_CR332","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/glia.22303","volume":"60","author":"KI Rathore","year":"2012","unstructured":"Rathore KI, Redensek A, David S (2012) Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1. Glia 60(5):738\u2013750. \n                    https:\/\/doi.org\/10.1002\/glia.22303","journal-title":"Glia"},{"issue":"3","key":"1092_CR333","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s12035-014-8671-3","volume":"50","author":"ZM Qian","year":"2014","unstructured":"Qian ZM, He X, Liang T, Wu KC, Yan YC, Lu LN, Yang G, Luo QQ et al (2014) Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6\/STAT3 signaling pathway. Mol Neurobiol 50(3):811\u2013820. \n                    https:\/\/doi.org\/10.1007\/s12035-014-8671-3","journal-title":"Mol Neurobiol"},{"issue":"7","key":"1092_CR334","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.bbadis.2015.03.011","volume":"1852","author":"B Silva","year":"2015","unstructured":"Silva B, Faustino P (2015) An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta 1852(7):1347\u20131359. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2015.03.011","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1092_CR335","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nchembio807","volume":"2","author":"TA Rouault","year":"2006","unstructured":"Rouault TA (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2(8):406\u2013414. \n                    https:\/\/doi.org\/10.1038\/nchembio807","journal-title":"Nat Chem Biol"},{"issue":"3","key":"1092_CR336","doi-asserted-by":"publisher","first-page":"e0118830","DOI":"10.1371\/journal.pone.0118830","volume":"10","author":"L Bornsen","year":"2015","unstructured":"Bornsen L, Romme Christensen J, Ratzer R, Hedegaard C, Sondergaard HB, Krakauer M, Hesse D, Nielsen CH et al (2015) Endogenous interferon-beta-inducible gene expression and interferon-beta-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis. PLoS One 10(3):e0118830. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0118830","journal-title":"PLoS One"},{"issue":"5 Suppl 1","key":"1092_CR337","doi-asserted-by":"publisher","first-page":"1510s","DOI":"10.1093\/jn\/133.5.1510S","volume":"133","author":"RS Eisenstein","year":"2003","unstructured":"Eisenstein RS, Ross KL (2003) Novel roles for iron regulatory proteins in the adaptive response to iron deficiency. J Nutr 133(5 Suppl 1):1510s\u20131516s","journal-title":"J Nutr"},{"issue":"23","key":"1092_CR338","doi-asserted-by":"publisher","first-page":"19738","DOI":"10.1074\/jbc.M100245200","volume":"276","author":"A Caltagirone","year":"2001","unstructured":"Caltagirone A, Weiss G, Pantopoulos K (2001) Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem 276(23):19738\u201319745. \n                    https:\/\/doi.org\/10.1074\/jbc.M100245200","journal-title":"J Biol Chem"},{"issue":"12","key":"1092_CR339","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/j.1460-2075.1995.tb07291.x","volume":"14","author":"K Pantopoulos","year":"1995","unstructured":"Pantopoulos K, Hentze MW (1995) Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J 14(12):2917\u20132924","journal-title":"EMBO J"},{"issue":"25","key":"1092_CR340","doi-asserted-by":"publisher","first-page":"7648","DOI":"10.1021\/bi030041i","volume":"42","author":"E Soum","year":"2003","unstructured":"Soum E, Brazzolotto X, Goussias C, Bouton C, Moulis JM, Mattioli TA, Drapier JC (2003) Peroxynitrite and nitric oxide differently target the iron-sulfur cluster and amino acid residues of human iron regulatory protein 1. Biochemistry 42(25):7648\u20137654. \n                    https:\/\/doi.org\/10.1021\/bi030041i","journal-title":"Biochemistry"},{"issue":"23","key":"1092_CR341","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1021\/bi025756k","volume":"41","author":"G Cairo","year":"2002","unstructured":"Cairo G, Ronchi R, Recalcati S, Campanella A, Minotti G (2002) Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of J774A.1 macrophages by direct disassembly of the Fe-S cluster of cytoplasmic aconitase. Biochemistry 41(23):7435\u20137442","journal-title":"Biochemistry"},{"issue":"3","key":"1092_CR342","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1006\/bcmd.2002.0579","volume":"29","author":"S Kim","year":"2002","unstructured":"Kim S, Ponka P (2002) Nitric oxide-mediated modulation of iron regulatory proteins: Implication for cellular iron homeostasis. Blood Cells Mol Dis 29(3):400\u2013410","journal-title":"Blood Cells Mol Dis"},{"issue":"16","key":"1092_CR343","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1111\/j.1742-4658.2006.05390.x","volume":"273","author":"M Mikhael","year":"2006","unstructured":"Mikhael M, Kim SF, Schranzhofer M, Soe-Lin S, Sheftel AD, Mullner EW, Ponka P (2006) Iron regulatory protein-independent regulation of ferritin synthesis by nitrogen monoxide. FEBS J 273(16):3828\u20133836. \n                    https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05390.x","journal-title":"FEBS J"},{"issue":"4","key":"1092_CR344","first-page":"761","volume":"46","author":"DJ Pinero","year":"2000","unstructured":"Pinero DJ, Hu J, Connor JR (2000) Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer\u2019s diseased brains. Cell Mol Biol (Noisy-le-Grand, France) 46(4):761\u2013776","journal-title":"Cell Mol Biol (Noisy-le-Grand, France)"},{"issue":"4","key":"1092_CR345","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3233\/jad-2009-1010","volume":"16","author":"S Altamura","year":"2009","unstructured":"Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of aging: Alzheimer\u2019s disease, Parkinson\u2019s disease and atherosclerosis. J Alzheimer\u2019s Dis : JAD 16(4):879\u2013895. \n                    https:\/\/doi.org\/10.3233\/jad-2009-1010","journal-title":"J Alzheimer\u2019s Dis : JAD"},{"issue":"9","key":"1092_CR346","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1212\/01.wnl.0000255938.33739.46","volume":"68","author":"L Guyant-Marechal","year":"2007","unstructured":"Guyant-Marechal L, Rovelet-Lecrux A, Goumidi L, Cousin E, Hannequin D, Raux G, Penet C, Ricard S et al (2007) Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology 68(9):684\u2013687. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000255938.33739.46","journal-title":"Neurology"},{"issue":"7","key":"1092_CR347","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbagen.2008.12.001","volume":"1790","author":"CM Cahill","year":"2009","unstructured":"Cahill CM, Lahiri DK, Huang X, Rogers JT (2009) Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta 1790(7):615\u2013628. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2008.12.001","journal-title":"Biochim Biophys Acta"},{"issue":"41","key":"1092_CR348","doi-asserted-by":"publisher","first-page":"31217","DOI":"10.1074\/jbc.M110.149161","volume":"285","author":"HH Cho","year":"2010","unstructured":"Cho HH, Cahill CM, Vanderburg CR, Scherzer CR, Wang B, Huang X, Rogers JT (2010) Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem 285(41):31217\u201331232. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.149161","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"1092_CR349","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1042\/bst0361282","volume":"36","author":"JT Rogers","year":"2008","unstructured":"Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ et al (2008) Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans 36(Pt 6):1282\u20131287. \n                    https:\/\/doi.org\/10.1042\/bst0361282","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"1092_CR350","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1471-4159.1995.64010307.x","volume":"64","author":"S Bodovitz","year":"1995","unstructured":"Bodovitz S, Falduto MT, Frail DE, Klein WL (1995) Iron levels modulate \u03b1-secretase cleavage of amyloid precursor protein. J Neurochem 64(1):307\u2013315. \n                    https:\/\/doi.org\/10.1046\/j.1471-4159.1995.64010307.x","journal-title":"J Neurochem"},{"issue":"5a","key":"1092_CR351","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/j.1582-4934.2008.00356.x","volume":"12","author":"L Silvestri","year":"2008","unstructured":"Silvestri L, Camaschella C (2008) A potential pathogenetic role of iron in Alzheimer\u2019s disease. J Cell Mol Med 12(5a):1548\u20131550. \n                    https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00356.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"1092_CR352","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbrc.2006.08.077","volume":"349","author":"EM Hwang","year":"2006","unstructured":"Hwang EM, Kim SK, Sohn JH, Lee JY, Kim Y, Kim YS, Mook-Jung I (2006) Furin is an endogenous regulator of alpha-secretase associated APP processing. Biochem Biophys Res Commun 349(2):654\u2013659. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2006.08.077","journal-title":"Biochem Biophys Res Commun"},{"key":"1092_CR353","doi-asserted-by":"publisher","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(14)70117-6","DOI":"10.1016\/s1474-4422(14)70117-6"},{"issue":"95","key":"1092_CR354","doi-asserted-by":"publisher","first-page":"20140165","DOI":"10.1098\/rsif.2014.0165","volume":"11","author":"J Everett","year":"2014","unstructured":"Everett J, Cespedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA et al (2014) Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer\u2019s disease peptide -amyloid (1-42). J R Soc Interface 11(95):20140165\u201320140165. \n                    https:\/\/doi.org\/10.1098\/rsif.2014.0165","journal-title":"J R Soc Interface"},{"issue":"6","key":"1092_CR355","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1021\/ic402406g","volume":"53","author":"J Everett","year":"2014","unstructured":"Everett J, Cespedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA et al (2014) Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer\u2019s disease peptide beta-amyloid. Inorg Chem 53(6):2803\u20132809. \n                    https:\/\/doi.org\/10.1021\/ic402406g","journal-title":"Inorg Chem"},{"issue":"95","key":"1092_CR356","doi-asserted-by":"publisher","first-page":"20140165","DOI":"10.1098\/rsif.2014.0165","volume":"11","author":"J Everett","year":"2014","unstructured":"Everett J, Cespedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA et al (2014) Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer\u2019s disease peptide beta-amyloid (1-42). J Royal Soc Interface 11(95):20140165. \n                    https:\/\/doi.org\/10.1098\/rsif.2014.0165","journal-title":"J Royal Soc Interface"},{"issue":"10","key":"1092_CR357","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.chembiol.2017.07.014","volume":"24","author":"ND Telling","year":"2017","unstructured":"Telling ND, Everett J, Collingwood JF, Dobson J, van der Laan G, Gallagher JJ, Wang J, Hitchcock AP (2017) Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer\u2019s disease. Cell Chem Biol 24(10):1205\u20131215.e1203. \n                    https:\/\/doi.org\/10.1016\/j.chembiol.2017.07.014","journal-title":"Cell Chem Biol"},{"issue":"3","key":"1092_CR358","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jmb.2011.12.057","volume":"416","author":"SO Dahms","year":"2012","unstructured":"Dahms SO, K\u00f6nnig I, Roeser D, G\u00fchrs K-H, Mayer MC, Kaden D, Multhaup G, Than ME (2012) Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain. J Mol Biol 416(3):438\u2013452. \n                    https:\/\/doi.org\/10.1016\/j.jmb.2011.12.057","journal-title":"J Mol Biol"},{"key":"1092_CR359","doi-asserted-by":"publisher","unstructured":"Leskovjan AC, Kretlow A, Lanzirotti A, Miller LM Synchrotron-based imaging detects metal and plaques in a mouse model of Alzheimer’s disease. In: 2007 I.E. 33rd Annual Northeast Bioengineering Conference, 10\u201311 March 2007 2007. pp 54\u201355. doi:\n                    https:\/\/doi.org\/10.1109\/NEBC.2007.4413276","DOI":"10.1109\/NEBC.2007.4413276"},{"issue":"4","key":"1092_CR360","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/s0891-5849(00)00494-9","volume":"30","author":"CA Rottkamp","year":"2001","unstructured":"Rottkamp CA, Raina AK, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G et al (2001) Redox-active iron mediates amyloid-\u03b2 toxicity. Free Radic Biol Med 30(4):447\u2013450. \n                    https:\/\/doi.org\/10.1016\/s0891-5849(00)00494-9","journal-title":"Free Radic Biol Med"},{"issue":"20","key":"1092_CR361","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1021\/bi7000032","volume":"46","author":"C Ha","year":"2007","unstructured":"Ha C, Ryu J, Park CB (2007) Metal ions differentially influence the aggregation and deposition of Alzheimer\u2019s \u03b2-amyloid on a solid template\u2020. Biochemistry 46(20):6118\u20136125. \n                    https:\/\/doi.org\/10.1021\/bi7000032","journal-title":"Biochemistry"},{"issue":"24","key":"1092_CR362","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SI Cohen","year":"2013","unstructured":"Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M et al (2013) Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A 110(24):9758\u20139763. \n                    https:\/\/doi.org\/10.1073\/pnas.1218402110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1092_CR363","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00775-004-0602-8","volume":"9","author":"X Huang","year":"2004","unstructured":"Huang X, Atwood CS, Moir RD, Hartshorn MA, Tanzi RE, Bush AI (2004) Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer\u2019s Abeta peptides. J Biol Inorg Chem: JBIC : a publication of the Society of Biological Inorganic Chemistry 9(8):954\u2013960. \n                    https:\/\/doi.org\/10.1007\/s00775-004-0602-8","journal-title":"J Biol Inorg Chem: JBIC : a publication of the Society of Biological Inorganic Chemistry"},{"issue":"6","key":"1092_CR364","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1074\/jbc.M110.158980","volume":"286","author":"B Liu","year":"2011","unstructured":"Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC, Hider R, Marciniak SJ et al (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem 286(6):4248\u20134256. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.158980","journal-title":"J Biol Chem"},{"key":"1092_CR365","doi-asserted-by":"publisher","unstructured":"Hare D, Ayton S, Bush A, Lei P (2013) A delicate balance: iron metabolism and diseases of the brain. Front Aging Neurosci 5(34). \n                    https:\/\/doi.org\/10.3389\/fnagi.2013.00034","DOI":"10.3389\/fnagi.2013.00034"},{"issue":"2","key":"1092_CR366","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","volume":"34","author":"C Guo","year":"2013","unstructured":"Guo C, Wang T, Zheng W, Shan Z-Y, Teng W-P, Wang Z-Y (2013) Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging 34(2):562\u2013575. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.05.009","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1092_CR367","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-2004-6610","volume":"6","author":"MA Lovell","year":"2004","unstructured":"Lovell MA, Xiong S, Xie C, Davies P, Markesbery WR (2004) Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J Alzheimer\u2019s Dis: JAD 6(6):659\u2013671 discussion 673-681","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"4","key":"1092_CR368","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3233\/JAD-2006-9405","volume":"9","author":"A Chan","year":"2006","unstructured":"Chan A, Shea TB (2006) Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. J Alzheimer\u2019s Dis: JAD 9(4):399\u2013405","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"1","key":"1092_CR369","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4067\/S0716-97602006000100021","volume":"39","author":"P Munoz","year":"2006","unstructured":"Munoz P, Zavala G, Castillo K, Aguirre P, Hidalgo C, Nunez MT (2006) Effect of iron on the activation of the MAPK\/ERK pathway in PC12 neuroblastoma cells. Biol Res 39(1):189\u2013190","journal-title":"Biol Res"},{"issue":"10","key":"1092_CR370","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/10715760701609061","volume":"41","author":"X Huang","year":"2007","unstructured":"Huang X, Dai J, Huang C, Zhang Q, Bhanot O, Pelle E (2007) Deferoxamine synergistically enhances iron-mediated AP-1 activation: a showcase of the interplay between extracellular-signal-regulated kinase and tyrosine phosphatase. Free Radic Res 41(10):1135\u20131142. \n                    https:\/\/doi.org\/10.1080\/10715760701609061","journal-title":"Free Radic Res"},{"issue":"2","key":"1092_CR371","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neuint.2012.12.005","volume":"62","author":"C Guo","year":"2013","unstructured":"Guo C, Wang P, Zhong M-L, Wang T, Huang X-S, Li J-Y, Wang Z-Y (2013) Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain. Neurochem Int 62(2):165\u2013172. \n                    https:\/\/doi.org\/10.1016\/j.neuint.2012.12.005","journal-title":"Neurochem Int"},{"issue":"2","key":"1092_CR372","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neurobiolaging.2005.01.016","volume":"27","author":"HM Schipper","year":"2006","unstructured":"Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27(2):252\u2013261. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.01.016","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1092_CR373","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3233\/jad-140567","volume":"43","author":"D Wang","year":"2015","unstructured":"Wang D, Hui Y, Peng Y, Tang L, Jin J, He R, Li Y, Zhang S et al (2015) Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice. J Alzheimer\u2019s Dis: JAD 43(2):519\u2013534. \n                    https:\/\/doi.org\/10.3233\/jad-140567","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"2","key":"1092_CR374","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1515\/revneuro-2013-0046","volume":"25","author":"J Chen","year":"2014","unstructured":"Chen J (2014) Heme oxygenase in neuroprotection: from mechanisms to therapeutic implications. Rev Neurosci 25(2):269\u2013280. \n                    https:\/\/doi.org\/10.1515\/revneuro-2013-0046","journal-title":"Rev Neurosci"},{"key":"1092_CR375","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00019052-200206000-00020","volume":"15","author":"V Perry","year":"2002","unstructured":"Perry V, Cunningham C, Boche D (2002) Atypical inflammation in the central nervous system in prion disease. Curr Opin Neurol 15:349\u2013354","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"1092_CR376","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.3390\/ijms14036044","volume":"14","author":"B Ruttkay-Nedecky","year":"2013","unstructured":"Ruttkay-Nedecky B, Nejdl L, Gumulec J, Zitka O, Masarik M, Eckschlager T, Stiborova M, Adam V et al (2013) The role of metallothionein in oxidative stress. Int J Mol Sci 14(3):6044\u20136066. \n                    https:\/\/doi.org\/10.3390\/ijms14036044","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1092_CR377","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0162-0134(01)00376-2","volume":"88","author":"KT Suzuki","year":"2002","unstructured":"Suzuki KT, Someya A, Komada Y, Ogra Y (2002) Roles of metallothionein in copper homeostasis: responses to cu-deficient diets in mice. J Inorg Biochem 88(2):173\u2013182. \n                    https:\/\/doi.org\/10.1016\/S0162-0134(01)00376-2","journal-title":"J Inorg Biochem"},{"issue":"5","key":"1092_CR378","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1134\/s0006297914050022","volume":"79","author":"EV Stelmashook","year":"2014","unstructured":"Stelmashook EV, Isaev NK, Genrikhs EE, Amelkina GA, Khaspekov LG, Skrebitsky VG, Illarioshkin SN (2014) Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer\u2019s and Parkinson\u2019s diseases. Biochemistry Biokhimiia 79(5):391\u2013396. \n                    https:\/\/doi.org\/10.1134\/s0006297914050022","journal-title":"Biochemistry Biokhimiia"},{"issue":"14","key":"1092_CR379","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1182\/blood-2014-08-594093","volume":"124","author":"S Nakahata","year":"2014","unstructured":"Nakahata S, Morishita K (2014) PP2A inactivation by ROS accumulation. Blood 124(14):2163\u20132165. \n                    https:\/\/doi.org\/10.1182\/blood-2014-08-594093","journal-title":"Blood"},{"issue":"6","key":"1092_CR380","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.biocel.2008.10.029","volume":"41","author":"L Chen","year":"2009","unstructured":"Chen L, Liu L, Yin J, Luo Y, Huang S (2009) Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int J Biochem Cell Biol 41(6):1284\u20131295. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2008.10.029","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"1092_CR381","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1073\/pnas.1322614111","volume":"111","author":"M Arif","year":"2014","unstructured":"Arif M, Kazim SF, Grundke-Iqbal I, Garruto RM, Iqbal K (2014) Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam. Proc Natl Acad Sci 111(3):1144\u20131149. \n                    https:\/\/doi.org\/10.1073\/pnas.1322614111","journal-title":"Proc Natl Acad Sci"},{"key":"1092_CR382","doi-asserted-by":"publisher","unstructured":"Zenaro E, Piacentino G, Constantin G (2017) The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol Dis 107:41\u201356. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2016.07.007","DOI":"10.1016\/j.nbd.2016.07.007"},{"issue":"11","key":"1092_CR383","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV (2017) Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J Exp Med 214(11):3151\u20133169. \n                    https:\/\/doi.org\/10.1084\/jem.20171406","journal-title":"J Exp Med"},{"key":"1092_CR384","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fimmu.2016.00033","volume":"7","author":"E Pietronigro","year":"2016","unstructured":"Pietronigro E, Zenaro E, Constantin G (2016) Imaging of leukocyte trafficking in Alzheimer\u2019s disease. Front Immunol 7:33. \n                    https:\/\/doi.org\/10.3389\/fimmu.2016.00033","journal-title":"Front Immunol"},{"issue":"4","key":"1092_CR385","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1042\/bst20140319","volume":"43","author":"KD Rochfort","year":"2015","unstructured":"Rochfort KD, Cummins PM (2015) The blood-brain barrier endothelium: a target for pro-inflammatory cytokines. Biochem Soc Trans 43(4):702\u2013706. \n                    https:\/\/doi.org\/10.1042\/bst20140319","journal-title":"Biochem Soc Trans"},{"key":"1092_CR386","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60:1\u201312. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2016.03.010","journal-title":"Brain Behav Immun"},{"issue":"5","key":"1092_CR387","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"35","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM (2015) Striatal blood\u2013brain barrier permeability in Parkinson\u2019s disease. J Cereb Blood Flow Metab 35(5):747\u2013750. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2015.32","journal-title":"J Cereb Blood Flow Metab"},{"key":"1092_CR388","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fncel.2014.00211","volume":"8","author":"R Cabezas","year":"2014","unstructured":"Cabezas R, \u00c1vila M, Gonzalez J, El-Bach\u00e1 RS, B\u00e1ez E, Garc\u00eda-Segura LM, Jurado Coronel JC, Capani F et al (2014) Astrocytic modulation of blood brain barrier: perspectives on Parkinson\u2019s disease. Front Cell Neurosci 8:211. \n                    https:\/\/doi.org\/10.3389\/fncel.2014.00211","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"1092_CR389","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurology 73(11):1316\u20131324. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742","journal-title":"JAMA Neurology"},{"key":"1092_CR390","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. \n                    https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"issue":"10","key":"1092_CR391","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/oem.2006.027003","volume":"64","author":"FD Dick","year":"2007","unstructured":"Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S et al (2007) Environmental risk factors for Parkinson\u2019s disease and parkinsonism: the Geoparkinson study. Occup Environ Med 64(10):666\u2013672. \n                    https:\/\/doi.org\/10.1136\/oem.2006.027003","journal-title":"Occup Environ Med"},{"issue":"4","key":"1092_CR392","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00115-017-0288-0","volume":"88","author":"CM Lill","year":"2017","unstructured":"Lill CM, Klein C (2017) Epidemiology and causes of Parkinson\u2019s disease. Nervenarzt 88(4):345\u2013355. \n                    https:\/\/doi.org\/10.1007\/s00115-017-0288-0","journal-title":"Nervenarzt"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1092-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T14:39:37Z","timestamp":1556548777000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1092-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,29]]},"references-count":392,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1092-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,29]]},"assertion":[{"value":"25 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}